EP1546723A4 - Reading of fluorescent arrays - Google Patents

Reading of fluorescent arrays

Info

Publication number
EP1546723A4
EP1546723A4 EP03788571A EP03788571A EP1546723A4 EP 1546723 A4 EP1546723 A4 EP 1546723A4 EP 03788571 A EP03788571 A EP 03788571A EP 03788571 A EP03788571 A EP 03788571A EP 1546723 A4 EP1546723 A4 EP 1546723A4
Authority
EP
European Patent Office
Prior art keywords
array
reader
substrate
anay
image
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP03788571A
Other languages
German (de)
French (fr)
Other versions
EP1546723A2 (en
Inventor
Jean I Montagu
Robert H Webb
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Decision Biomarkers Inc
Original Assignee
Decision Biomarkers Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=31892097&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EP1546723(A4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Decision Biomarkers Inc filed Critical Decision Biomarkers Inc
Publication of EP1546723A2 publication Critical patent/EP1546723A2/en
Publication of EP1546723A4 publication Critical patent/EP1546723A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64Fluorescence; Phosphorescence
    • G01N21/645Specially adapted constructive features of fluorimeters
    • G01N21/6452Individual samples arranged in a regular 2D-array, e.g. multiwell plates
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64Fluorescence; Phosphorescence
    • G01N21/6428Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64Fluorescence; Phosphorescence
    • G01N21/645Specially adapted constructive features of fluorimeters
    • G01N21/6456Spatial resolved fluorescence measurements; Imaging
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54393Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00277Apparatus
    • B01J2219/00279Features relating to reactor vessels
    • B01J2219/00306Reactor vessels in a multiple arrangement
    • B01J2219/00313Reactor vessels in a multiple arrangement the reactor vessels being formed by arrays of wells in blocks
    • B01J2219/00315Microtiter plates
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00277Apparatus
    • B01J2219/00351Means for dispensing and evacuation of reagents
    • B01J2219/00387Applications using probes
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00277Apparatus
    • B01J2219/00497Features relating to the solid phase supports
    • B01J2219/00527Sheets
    • B01J2219/00533Sheets essentially rectangular
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583Features relative to the processes being carried out
    • B01J2219/00603Making arrays on substantially continuous surfaces
    • B01J2219/00605Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583Features relative to the processes being carried out
    • B01J2219/00603Making arrays on substantially continuous surfaces
    • B01J2219/00605Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
    • B01J2219/00612Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports the surface being inorganic
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583Features relative to the processes being carried out
    • B01J2219/00603Making arrays on substantially continuous surfaces
    • B01J2219/00605Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
    • B01J2219/00632Introduction of reactive groups to the surface
    • B01J2219/00637Introduction of reactive groups to the surface by coating it with another layer
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583Features relative to the processes being carried out
    • B01J2219/00603Making arrays on substantially continuous surfaces
    • B01J2219/00639Making arrays on substantially continuous surfaces the compounds being trapped in or bound to a porous medium
    • B01J2219/00641Making arrays on substantially continuous surfaces the compounds being trapped in or bound to a porous medium the porous medium being continuous, e.g. porous oxide substrates
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00718Type of compounds synthesised
    • B01J2219/0072Organic compounds
    • B01J2219/00722Nucleotides
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00718Type of compounds synthesised
    • B01J2219/0072Organic compounds
    • B01J2219/00725Peptides
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00718Type of compounds synthesised
    • B01J2219/0072Organic compounds
    • B01J2219/0074Biological products
    • CCHEMISTRY; METALLURGY
    • C40COMBINATORIAL TECHNOLOGY
    • C40BCOMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00Libraries per se, e.g. arrays, mixtures
    • C40B40/04Libraries containing only organic compounds
    • C40B40/06Libraries containing nucleotides or polynucleotides, or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C40COMBINATORIAL TECHNOLOGY
    • C40BCOMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00Libraries per se, e.g. arrays, mixtures
    • C40B40/04Libraries containing only organic compounds
    • C40B40/10Libraries containing peptides or polypeptides, or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C40COMBINATORIAL TECHNOLOGY
    • C40BCOMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B60/00Apparatus specially adapted for use in combinatorial chemistry or with libraries
    • C40B60/14Apparatus specially adapted for use in combinatorial chemistry or with libraries for creating libraries
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/25Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
    • G01N21/27Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands using photo-electric detection ; circuits for computing concentration
    • G01N21/274Calibration, base line adjustment, drift correction

Definitions

  • the field to which this disclosure relates is clinical micro-array technology, for instance clinical research and clinical diagnosis.
  • Micro-array technology has developed over the past decade and more. It is employed in the investigation of biological molecules, in particular, nucleic acid and amino acid materials. Effective use has been made of the technology in understanding the genome and in drug discovery. It has been predicted that the technology would ultimately develop to enable practical use in the clinic, e.g. for clinical investigations and clinical diagnosis, but that prospect has seemed far off. Among reasons for this being only a long-term hope has been the very high cost of the required equipment, the time involved in carrying out assays, and the high level of experience and skill required. As is well known, micro-arrays are used by creating a field of features or spots of different analytes that are tagged or marked if certain components are present.
  • fluorescent tags While marking has often been by radioisotope tags, fluorescent tags have come into wide usage for a number of reasons including the ease by which the materials can be handled and out of safety considerations. Typically it is desired to represent an assay by a complete image of an array, or small set of related arrays.
  • the reader of fluorescent micro-arrays is key to the use of the arrays.
  • the reader records presence and degree of fluorescence at each of the precisely located features in the array in response to exposure to photoexcitation. After consideration of numerous arrangements for reader design, a few successful technologies have found acceptance. These universally have required precise and costly mechanical movements, as well as extensive optics or software. In one case, a rapidly oscillating scanner arm moves a tiny lens for reading one pixel at a time in one coordinate, in a confocal configuration, while the image of the array in the other coordinate is developed by precise, gradual advance using a microscope stage.
  • the stage is a device that creates precise movements of micron or sub micron accuracy and is costly to manufacture and along with the other components.
  • software is used to assemble the image from the vast array of gathered pixels.
  • Another technique has been to image highly magnified views of portions of the overall array, by use of precision stage movement between the taking of each of the series of magnified images of the small portions of the array, and then electronically merging or "stitching" the small field image frames together to electronically produce an image of the complete array.
  • Prior proposals or speculation for employing a solid state array of sensors to image an entire array at one taking have not resulted in practical solution of the entire set of problems, i.e., simultaneously achieving high accuracy and high speed of operation at reasonable cost.
  • Embodiments can satisfy the crucial low cost need for a clinical reader, along with need for reasonably high speed and ease of operation, and while achieving the high level of accuracy required for medical use.
  • the basic reader geometry should be based on dark field illumination, e.g. light reaching the two-dimensional array at an acute angle of 20 to 50 degrees, which should be mated with two-dimensional imaging on a solid-state detector array, such as that of a CCD sensor or CMOS array, with mapping on that array being of a scale of the same order of magnitude as the array of biological features.
  • NA numerical aperture
  • Embodiments within these constraints are capable of imaging an entire array in a single frame, without movement or stitching of components of the array. It is realized that cooperation of the features in the instrument, preferably with further novel enhancements to be described, can make up for the inherent limitations of such an arrangement, i.e. its relatively large depth of field, and, when using preferred relatively inexpensive lighting, such as by high intensity diodes, its non-uniform illumination.
  • the resulting apparatus because of its simplicity and lack of precise moving parts or expensive optics, can be made available to clinics at a cost that makes the system and technique practical. In such manner, practical, high-speed clinical imaging is made possible even now, and from this, great benefits to medicine and patient care can be obtained.
  • an array reader is provided that is suitable for clinical purposes for reading a two-dimensional array of features on a planar substrate, in which the features carry photo-responsive markers, the markers capable of emitting light upon excitation, the array reader comprising an illumination system for simultaneously exciting multiple photo-responsive markers distributed in a two-dimensional array over the substrate, and an image collection and recording system having a field of view for emissions from the markers on the substrate, wherein the illumination system comprises a light source arranged to flood the two-dimensional array with light at an excitation wavelength, along an illumination path disposed at an angle ⁇ between about 20 and 50° to the plane of the substrate, the image collection and recording system having an image-acquiring axis substantially normal to the plane of the substrate carrying the array, employing a two-dimensional sensor comprising a solid-state array of photosensitive elements, e.g.
  • CMOS complementary metal-oxide-semiconductor
  • the image collection and recording system constructed and arranged to apply an image of the array of markers upon the solid-state array of size of the same order of magnitude as the size of the array, e.g. within a range of magnification of up to about 25% or reduction down to about 75%, the image collection, and recording system having an intermediate numerical aperture NA, to enable recording the image of fluorescence from the excited two-dimensional array with clinical accuracy and without translation of the array.
  • the array reader image collection and recording system has its nearest component spaced at least 5 mm, preferably at least 10 millimeter, from the substrate or its support, the component constructed and arranged to provide space below the component for the illumination path to the two-dimensional array on the substrate.
  • the image collection and recording system has a field of view on the substrate of areas between about 50 mm 2 and 300 mm 2 .
  • the illumination system comprises one or more light-emitting diodes.
  • the illumination system and especially the diode-based system, is constructed and arranged to provide excitation illumination over the two-dimensional array on the substrate of a power density greater than 30 mW/cm 2 and preferably the image collection and recording system includes a timer cooperatively related to the illumination system to provide exposure sufficient to produce a fluence of excitation radiation at the substrate greater than about 15 mJ/cm 2 across the two-dimensional array.
  • the array reader has a field of view of diameter of the order of 10 mm or more.
  • Each feature of the array of interest is imaged onto a minimum of 50 pixel elements of the solid state array, for example upon CCD or CMOS elements.
  • the pixels (i.e. sensor elements) of the solid state array are selected to be of 9 micron dimension, albeit, if larger field were to be imaged, using the same arrangement, pixels down to about 4.5 micron may be selected, and more reduction of image may be employed).
  • the array reader is constructed and arranged to deliver to the solid state sensor an image of the field of view that is not magnified, preferably the reader being constructed and arranged to deliver to the solid state sensor array an image of the field of view reduced between about 30% and 50%.
  • the array reader is constructed to image spots each of diameter at least about 80 micron, preferably at least 100 micron diameter.
  • the array reader is constructed and arranged to produce, during a single imaging interval, an image of an array of at least 100 spots each of 300 micron diameter, or of at least 400 spots each of 150 micron diameter.
  • the array reader is combined with a carrier for the array comprising a substrate layer carried by a support body, the image collection and recording system residing on the same side of the substrate as does the array of features such that the path of illumination reaches the array before reaching the support body, the carrier constructed to absorb excitation radiation penetrating beyond the layer, preferably the support body being transparent, e.g. glass, and between the substrate layer and the transparent body resides a substantially opaque adherent layer capable of substantially blocking excitation radiation tending to enter the transparent body, preferably the substantially opaque layer comprising a layer of metal oxide.
  • the array reader is combined with a carrier for the array in the form of a transparent layer carried by a transparent body, the image collection and recording system lying beyond the transparent body on the same side of the array as the transparent body.
  • the array reader is combined with a carrier for the array that comprises an ultra- thin substrate layer on a support body, i.e. the substrate having a thickness less than 5 micron, preferably less than about 3 micron.
  • the array reader is combined with a carrier in which the array is disposed on a substrate comprising a clear layer of nitrocellulose or polystyrene.
  • the array reader is combined with a carrier in which the substrate is a nitrocellulose membrane that is porous at least in its outer region.
  • the array reader is combined with a substrate carrying excitation energy reference features distributed across the two-dimensional array of features, the image collection and recording system including a normalizing arrangement for normalizing data detected in the vicinity of respective reference features based on the quantity of detected emission from the respective reference features.
  • the array reader has an illumination system which comprises at least two different light source sub-systems respectively of substantially different wavelengths, each associated with a respective optical system delivering light along a path, the paths of the sub-systems to the substrate lying along respectively different axes, the axes being spaced apart about the substrate, in certain preferred embodiments there being two different light source subsystems the paths of which are disposed on diametrically opposite positions about the substrate.
  • the array reader has an illuminating system which includes light sources selected respectively to excite Cy3 and Cy5, and the image collection and recording system includes changeable band-pass filters suitable to permit passage of emissions respectively from Cy3 and Cy5 or a single band-pass filter is provided suitable to permit passage of multiple band-pass emissions such as both the band-pass emission of Cy3 and of Cy5.
  • the image collection and recording system of the array reader is adjustable between at least two settings, the first and second settings constructed and arranged respectively to form a single image of an array format of dimensions 6.5 mm x 9.0 mm and of an array format comprising two separated sub-windows, each of dimensions 4.5 mm x 4.5 mm disposed within a 4.5x 13.5 mm rectangle.
  • the array reader illumination system includes a diode light source and a homogenizer effective to reduce variation in flux density across the field of illumination, in certain preferred embodiments the homogenizer comprising an elongated transparent, internally reflective rod, which may be straight or curved and may have round, square or rectangular cross section, and be twisted or untwisted.
  • the array reader has an image collection and recording system constructed and arranged to resolve the image on the solid state sensor array at resolution no finer than about 10 micron, in certain preferred embodiments the resolution being between about 12 and 15 micron.
  • the array reader has an image collection and recording system which includes an interference filter, collection optics of the system preceding the filter constructed to direct collected rays in parallel to the filter, and imaging optics constructed to image parallel rays leaving the filter upon the solid state sensor.
  • the array reader is constructed to be used with an array support that holds more than one array, and wherem the reader is constructed and arranged to read and process each array as an independent array.
  • the invention also includes a method of conducting an assay comprising preparing a two-dimensional spotted array of amino or nucleic acid features on a substrate, preferably by spotting liquid samples thereon, in which features in the array carry fluorescent markers and employing the reader of any of the foregoing descriptions to read the array.
  • Preferred embodiments of this aspect of the invention have one or more of the following technical features.
  • the assay is a diagnostic immuno assay based on protein derived from blood, in certain embodiments preferably the immunoassay is of an antibody capture configuration, for instance adapted, by immobilized antibodies to detect or monitor for malignant cancer, e.g. to detect ovarian cancer for initial diagnosis or to monitor patients at risk for relapse.
  • the substrate is disposed within a sealed disposable bio-cassette and imaging is performed through a transparent window visually accessing the substrate, or a transparent body forming a side of the bio-cassette carries the substrate, the substrate being transparent and the array being accessed visually by the array reader through the transparent body and through the substrate.
  • the array for reading an array on a substrate, in certain preferred embodiments the array includes intensity calibration markers of fluorescing character generally proportional in emission intensity to excitation level over the range of operable illumination intensities, and the system or method includes forming an image of the array employing the array reader, and normalizing recorded array data based on quantitative data acquired from nearby intensity calibration markers.
  • Another aspect of the invention is a fluorescence reader-based diagnostic method for a disease for which there is a set of known protein biomarkers in blood or other body constituent, comprising the steps of (1) providing a two-dimensional array of different reagents on a substrate, the reagents respectively specific to bind members of a set of the biomarkers capable of diagnosing the disease, (2) exposing the array to fluorophore-labeled blood or body-constituent extract of an individual containing the biomarkers if present in the individual's blood or body constituent, (3) while the array is stationary, exciting the array by simultaneously illuminating the entire two- dimensional array by light at fluorophore-excitation wavelength, by employing dark field illumination, (4) capturing a fluorescence image of the entire two-dimensional excited array on a single frame of an imager comprising a solid state array, and (5) analyzing (e.g. by computer) the fluorescence image for the presence of the disease.
  • Preferred embodiments of this aspect of the invention have
  • the method is performed in which the step of simultaneously illuminating the entire two-dimensional array is carried out by directing excitation radiation from a diode or set of diodes to produce illumination at a wavelength selected to excite the fluorophore, at a power density of at least 30m /cm 2 .
  • the method is carried out in a way in which fluorescence intensity reference features are distributed through the array and the detected radiation from the biomarkers is normalized by the reader based on the response of the references to the illumination.
  • the method is carried out in a way in which at least 50 pixels of the solid-state sensor represent the image of a feature of the array.
  • the method is performed in which the biomarkers attach to antibodies.
  • the method is performed in a way in which the array is formed to immobilize protein biomarkers selected to diagnose presence of ovarian cancer.
  • Another aspect of the invention is a method of reading an array on a substrate having features that include fluorophores, in which the array includes intensity calibration features of fluorescing character generally proportional in emission intensity to their illumination over the range of operable illumination intensities, including, forming an image of the array employing an array reader, and normalizing recoded array data based on quantitative data acquired during the reading of the array from nearby intensity calibration features within the array.
  • the method is adapted to perform diagnosis for a disease for which there is a set of known protein biomarkers in blood or other body constituent, comprising the steps of (1) providing a two-dimensional array of different reagents on a substrate, the reagents respectively specific to bind members of a set of the biomarkers capable of diagnosing the disease, and including with the array the intensity calibration features (2) exposing the array to fluorophore-labeled blood or body-constituent extract of an individual containing the biomarkers if present in the individual's blood or body constituent, (3) while the array is stationary, exciting the array by simultaneously illuminating the entire two-dimensional array by light at fluorophore-excitation wavelength employing dark field illumination, (4) capturing a fluorescence image of the entire two-dimensional excited array on a single frame of an imager comprising a solid state array, (5) normalizing the recorded array data based on the calibration features in the array and (6) analyzing
  • the method is performed by illuminating the entire two-dimensional array for forming the image by directing excitation radiation from a diode or set of diodes to produce illumination at a wavelength selected to excite the fluorophore, at a power density of at least 30mW/cm 2 .
  • the method is performed under conditions in which at least 50 pixels of a solid- state sensor represent the image of a feature of the array.
  • the method is employed to perform a diagnosis in which features of the array include antibodies, in one important case the features of the array are selected to diagnose the presence of ovarian cancer.
  • FIG. 1 is a diagrammatic view of an array reading system.
  • FIGs. 2 A and 2B are diagrammatic views of illuminating devices for the reader.
  • FIG. 3 is a plot of relative intensity of illumination versus angle relative to a central axis for a high intensity LED.
  • FIG. 4 A depicts a spotting pin and reservoir suitable to form spots of biological material or intensity calibration spots
  • FIG. 4B depicts an array in which the calibration spots are strategically distributed through the array of spots of biological material
  • FIG. 4C being a magnified view
  • FIG. 4D a plan view.
  • FIG. 5 depicts the mapping of a spot upon the array of solid state detection elements of the sensor.
  • FIG. 6 is a diagrammatic representation, on highly magnified scale, of a carrier comprising a transparent rigid support body, bearing an opaque layer, ultra-thin substrate and spots of the array on the substrate. Illumination from the same side as the array is shown.
  • FIG. 7 A is a diagrammatic representation of a preferred clinical array reader, while FIG. 7B shows another clinical array reader.
  • FIG. 8 illustrates two array formats imageable by the array reader of FIG. 7 A.
  • FIG. 9 is a diagram representing the steps of an array-reading method.
  • FIG. 10 is a diagram representing the steps of a method for normalizing the intensity level of pixels in the recorded image.
  • FIG. 11 is a diagram representing the steps of a fluorescence reader-based diagnostic method.
  • an array reading system 100 includes an array reader 110, a substrate 102 bearing a two-dimensional array of features 103 (e.g. spots of bio- material such as amino or nucleic acid) some of which, depending on the assay, carry fluorescent material, and a computer 104 for processing images recorded with the array reader 110.
  • the array reader 110 includes an illumination system 120 and an image collection and recording system 140.
  • the substrate 102 is positioned, with a positioner 105, below the image collection and recording system 140, with a distance between them h that is large enough for light from the illumination system 120 to flood the two dimensions of the array 103, preferably h having the value of at least 5 mm and generally preferably at least 10 mm.
  • a preferred source of the illuminating light has an output between about
  • the features on the substrate contain material capable of emitting light within a narrow fluorescence spectrum upon excitation with light of selected wavelength from the illumination system 120. Any available fluorescent dye maybe employed, presently Cy3 and Cy5 being common selections.
  • the image collection and recording system 140 collects the fluorescent light and records a resulting image of the features or spots, the optical system selected to produce a flat field of view.
  • the image-acquiring axis 141 is substantially normal to the plane of the substrate 102.
  • the illumination system 120 uses dark field illumination such that light from the illumination system 120 is directed along a path that has an angle ⁇ between about 20° and 50° to the plane of the substrate 102 to prevent illumination light reflected from the substrate 102 from entering the image collection and recording system 140.
  • the imaging optics 142 project an image 144 of the array 103 on a two-dimensional array of solid state detecting elements comprising sensor 146.
  • This solid state array is of dimensions of the same order of magnitude as are the dimensions of the array of bio- material spots.
  • the imaging optics system 142 is designed to have such a large field- of-view that the entire array 103 is mapped onto the sensor 146.
  • the two arrays are relatively sized such that a spot of bio-material is resolved on at least 50 pixels, preferably with spot size of the order of 100 micron, of the order of 100 pixels, or with spot size of 300 micron, of the order of 300 pixels.
  • the physical size Dj of the image 144 is approximately the same as the physical size D 0 of the array 103, biased toward reduction, i.e. preferably not magnified more than about 25% or reduced more than about 75%.
  • the array is not magnified, and preferably is reduced in the range between 30% and 50%. This provides the very important feature of there being no requirement to translate the array 103 by a precision stage relative to the reader 110 to acquire the image or stitch together multiple images of small sections to form a single image of the array 103.
  • the illumination system 120 includes a high intensity LED 122 for emitting light within an excitation band (e.g., green) designed to excite a fluorescence spectrum of a material in a spot (e.g., Cy3).
  • An excitation filter 124 is used to further limit the excitation wavelength band.
  • the spatial distribution of the light is shaped with an optical system such as a pair of lenses 126 and 128 for near uniform illumination of the two-dimensional array 103 on the substrate 102.
  • more than one LED can be distributed about the array 103, also arranged to emit light along a path that has an angle ⁇ between about 20° and 50° to the plane of the substrate 102.
  • the illumination system 120 includes a high intensity LED 122 for emitting light within an excitation band (e.g., green) designed to excite a fluorescence spectrum of a material in a spot (e.g., Cy3).
  • An excitation filter 124 is used to further limit the excitation wavelength band.
  • the spatial distribution of the light is
  • a homogenizer 130 with suitable lenses integral with its ends (not shown) reduces variation in flux density across the field of illumination onto the two-dimensional array 103 situated on the substrate 102. It comprises a solid transparent rod suitably designed or clad to have 100% internal reflection and of length relative to diameter selected to produce the desired homogenization effect, to render the distribution of illumination more uniform function.
  • the homogenizer 130 accepts light up to an acceptance angle of approximately 45°.
  • the end of the homogenizer 130 is arranged to emit light along a path that has an angle ⁇ between about 20° and 50° to the plane of the substrate 102.
  • the detected intensity for spots of an array can be normalized against the detected value of radiation received from near-lying calibration spots during image processing, thus enabling tolerance of non-uniformity in radiation, as may occur in a 0 low cost lighting system.
  • the technique may also be effective to compensate for imprecise location of the array under the reader.
  • FIG. 3 shows a non-uniform illumination pattern generated by a typical high-intensity LED, plotted as relative intensity as a function of angle from the center axis.
  • the intensity of fluorescent light recorded by the solid state sensor array at a location in the image corresponding to a calibration spot is used to infer the local illumination intensity, which is used to normalize the signal level recorded at neighboring spots on the sensor array.
  • Different calibrating spots typically local, respectively, to different sets of spots of unknown intensity are used.
  • FIG. 4A depicts a well of a microwell plate containing a fluorescent calibration composition in which a pin 161 is dipped to receive the composition for spotting a substrate 102 e.g. polyimide polymer (KaptonTM) dissolved in a volatile solvent.
  • FIG. 4B shows diagrammatically a spotted array 103 of biological spots 1 6 among which is a pattern of fluorescent calibration spots 164 produced with the composition of FIG. 4A.
  • FIG. 4C is a magnified view of a portion of a substrate 102 containing, in addition to biological spots 166, fluorescent intensity calibration spots 164.
  • FIG. 4A depicts a well of a microwell plate containing a fluorescent calibration composition in which a pin 161 is dipped to receive the composition for spotting a substrate 102 e.g. polyimide polymer (KaptonTM) dissolved in a volatile solvent.
  • FIG. 4B shows diagrammatically a spotted array 103 of biological spots 1 6 among which is a pattern
  • 4D is a diagrammatic plan view, on an enlarged scale, of an array 103 of biological spots 166, showing a relative arrangement of calibration spots 164. This arrangement enables normalization of intensity variations across the entire array 103.
  • the same intensity calibration spots can also be used as spatial fiducials for locating the array or the overall outline of the array may be employed for locating it to the control system.
  • FIG. 5 shows a section of a CCD near a border of the image of a spot 202 corresponding enabling resolution of a feature in the array by approximately 291 pixels.
  • FIG. 6 illustrates important aspects of a preferred substrate 102.
  • An ultra-thin layer 302 of material e.g., thinner than about 5 microns, preferably less than 3 microns
  • nitrocellulose or polystyrene As a film it is transparent, though in other cases an ultra-thin porous nitrocellulose membrane may be employed.
  • the substrate supports the array 103 of features. The being ultra-thin, it limits the amount of fluorescence emitted by the substrate layer 302 itself.
  • An opaque layer 304 such as sputtered metal-oxide helps to prevent illumination light 300 from penetrating into, and exciting fluorescence within, the rigid support 306 below (e.g. the substance of a glass microscope slide). This helps to counter potential auto-fluorescence capture from the support layer 306 caused by the large depth of focus due to not using a high numerical aperture optical system.
  • the array reader 110 enables imaging of an array of fluorescently labeled proteins, as well as other potential widespread uses, such as imaging proteins labeled with luminescent tags, and with other bio-materials labeled with fluorescent or luminescent tags.
  • the array reader 110 may be used to advantage with viruses, peptides, antibodies, receptors, and other proteins; with a wide range of other labeled biological materials including plant, animal, human, fungal and bacteria cells; and with labeled chemicals as well.
  • the array reader 110 is designed for rapid imaging of immunoassay arrays of the size relevant to clinicians, with typically fewer than 1000 spots.
  • the array reader 110 also enables performing immunoassays of multiple biomarkers (e.g., for ovarian cancer) simultaneously. Diseases with a set of known protein biomarkers in blood or other body constituents, can therefore be diagnosed more easily. After providing a two-dimensional spotted array of reagents on a substrate, the reagent spots are exposed to fluorophore-labeled blood or other body- constituent extracted from an individual suspected of having the disease. The resulting array of spots are then read by the array reader 110.
  • multiple biomarkers e.g., for ovarian cancer
  • Array reader 400 includes a LumiLed high intensity LED 402 (Luxeon green 535 nm, 5 watt LED, part # LXHL-LM5C available from Lumileds Lighting U.S., LLC, San Jose, CA) with a green peak wavelength for excitation of Cy3, and a second LumiLed high intensity LED 404 (Luxeon red-orange 617 nm, 1 watt LED, part # LXH-MH1B) with a peak wavelength for excitation of Cy5.
  • LumiLed high intensity LED 402 (Luxeon green 535 nm, 5 watt LED, part # LXHL-LM5C available from Lumileds Lighting U.S., LLC, San Jose, CA) with a green peak wavelength for excitation of Cy3
  • a second LumiLed high intensity LED 404 (Luxeon red-orange 617 nm, 1 watt LED, part # LXH-MH1B) with a peak wavelength for excitation of Cy5.
  • Both LEDs have a low temperature coefficient, of about 0.04 nm/deg C, and a narrow band peak wavelength tolerance, typically 8nm for Cy5 and 30 nm for Cy3. These LEDs are available with a 10% to 20% conversion efficiency and a typical specification of 110 mW of continuous-wave output power that can be peaked by 50% for a second at low duty cycle to yield about 150 mW, nearly all within the pass bands of a Cy3 excitation filter 406 (Chroma filter part # HQ 535/50, available from Chroma Technologies, Rockingham, NT) and the Cy5 excitation filter 408 (Chroma filter part # HQ 620/60). The f/1 cone (marked by lines 150 at 30° in the illumination pattern shown in FIG.
  • LEDS have a long life, and allow straightforward implementation of multicolor fluorescence.
  • the green LED 402 uses a pair of Kohler lenses 412, and the red- orange LED 404 uses a pair of Kohler lenses 414, so that both LEDs deliver a nearly uniform beam over the 6.5 x 9.5 mm 2 field-of-view of the array 103.
  • the LEDs are mounted on heat sinks available from their supplier.
  • Positioning of the substrate 102 relative to the viewing axis of the reader is performed by a positioner 105, e.g. a Geneva drive, with spatial resolution e.g. of 0.1 or 0.2 millimeter having a positional accuracy for instance of about 0.1 - 0.2 mm.
  • the positioner 105 can be used to automatically shift from imaging one array to another, either on the same or a different substrate, but of course is not of the precision or cost of a microscope stage and plays no part in generating the components of an image of the array.
  • the same substrate can carry many arrays without the need to precisely position the arrays relative to one another, and the positioner 105 acts to move one after another into position for imaging.
  • the substrate has alignment marks, "fiducials", that aid in the positioning, for instance sets of distinctive marks that designate the comers of rectangular arrays.
  • the array 103 is imaged onto the CCD sensor 420 by a pair of commercial CCD lens assemblies 422, 422' (Westech CCD lens assemblies #2105 and #2131, available from Westech Optical Corporation, Penfield, NY), lens 422 being used in an unusual way relative to the purpose of its original design.
  • a band-pass filter 424 (Chroma Technology part # 68030 for Cy5, Chroma part # 57030 for Cy3) located in between the two lenses selectively transmits only light within the excited fluorescence spectra.
  • the image of one 6.5 x 9.5 mm field-of-view (see 502, Fig. 8) is projected onto the CCD sensor 420 reduced by a factor of 0.707, whereas the image of two separated sub- arrays, lying in a rectangle 4.50 x 13.5 mm is reduced by a factor of 0.5.
  • the lenses are assembled to operate with a 0.42 NA on the object side (facing the array 103).
  • the array 103 can be imaged onto the CCD sensor 420 with the lens assemblies 422 assembled to operate with an NA as large as 0.52.
  • the CCD sensor 420 is cooled with a Peltier cooler 426 (as in the CCD-based camera from Santa Barbara Instrument Group, Inc., Santa Barbara, CA, Model ST-7x ME) to reduce dark current noise.
  • the cooler 426 has the capability to cool the CCD sensor 420 to 50° C below ambient if necessary.
  • read-out noise generated upon conversion of the stored charge in a pixel into a voltage, is a dominant source of noise and to the extent its effects are not eliminated, read-out noise determines the minimum light intensity that can be detected. As this noise is random and the fluorescent light from the spots is not, most of its effects can be reduced by the "on board binning," dark field subtraction, time and frame integration, software analysis, and using a large number of pixels imaging each spot.
  • imaging in a dark field mode may also be accomplished with direct illumination at angle ⁇ as shown and CCD sensor 24 positioned to view the array along axis A normal to the plane of the array via collection optics 27, spaced a distance h from the substrate.
  • the substrate layer may be microporous partially or throughout its depth or may be a solid film or a modified solid film, preferably in any of these cases being an ultra-thin coating or membrane of less than 5 micron thickness.
  • light for direct illumination enters along an illumination axis A', at an acute angle ⁇ to the plane of the array.
  • Distance h must be selected to enable such direct illumination, with angle ⁇ ranging between about 20° and 50°, here shown at 45°.
  • Light L originates from a source 112a, 112b or 112c of wavelength selected to excite the fluorophore tag of the array, passes via dichroic mirrors 156b, 156c to mirror 116 located to the side that directs the illumination along axis A' at angle ⁇ , onto the fluorophore-tagged array of spots resident on the ultra-thin substrate 20 or 20'.
  • the array of spots may use a carrier that comprises an ultra-thin substrate layer on a support body, or a carrier in the form of a transparent layer carried by a transparent body, the image collection and recording system lying beyond the transparent body on the same side of the array as the transparent body.
  • the fluorescent emissions are collected by lens 27, through a selected filter 28A, B or C, thence through lens 26 to CCD camera 24 under computer control 32.
  • the background subtraction technique is used with this system.
  • the immunoassay arrays are limited to 400 microassay spots.
  • the array format is then an important design issue.
  • the size and number of pixels of the CCD's chip and the configurations of commercial spotting arrayers are important constraints to be balanced against each other in the design of the reader and array.
  • the size of the array must be matched to the CCD's parameters.
  • spotter pin or tip configurations limit the choice of reservoirs for loading the spotting or printing head with source material, and also limit possible array configurations.
  • Disposable microtiter plates with either 96 or 384 wells are the typical reservoirs used.
  • a first format 502 field-of-view covers one 6.5 x 9.5 mm 2 array
  • a second format 504 field-of-view covers two 4.5 x 4.5 mm arrays.
  • 300-micron diameter spots, 500 microns on center yielding a spot occupancy of 36%
  • each spot will be conjugated to about 291 pixels.
  • 150-micron diameter spots, 333 microns on center each spot will be conjugated to about 91 pixels.
  • the large number of pixels per spot permits the on board 3x 3 binning option available with the CCD sensor to increase signal-to-noise ratio.
  • the immediate background is subjected to the same averaging to yield a sensitive and reliable fluorescence signal level.
  • Arrays can be formed with each of the formats using either of the two spot sizes. These arrays can be printed with all commercial arrayers/printers, such as the Affymetrix Pin and Ring Arrayer, starting with either 96 or 384 microtiter plates as the source material loading reservoir.
  • the signal-to-noise ratio improves as the square root of the ratio of integration time or the number of frames. A 5 second read time versus 0.5 seconds improves the signal-to-noise ratio by approximately 3.16 times.
  • the signal-to-noise ratio can also be increased by increasing the number of
  • LEDs e.g. to as many as 4 for each of the 2 wavelengths, to raise the power level to 160mW/cm2.
  • these options increase the signal to noise ratio by as much as a factor of 13 by substantially raising the fluence to l,120mJ/cm 2 .
  • Photo- bleaching a possible consequence, depending upon the dyes etc., may limit this approach in particular circumstances.
  • the substrate can be a glass slide, or alternatively, a sealed disposable bio-cassette where imaging is performed through a transparent window within the substrate.
  • a method for multi-biomarker assay includes the step 600 of providing a two-dimensional spotted array of amino or nucleic acid features on a substrate, where features throughout the array carry photo-responsive sensitive markers.
  • the illumination source of the array reader illuminates the array along an illumination path at an angle ⁇ between about 20 and 50° to the plane of the substrate.
  • the image collection and recording system then collects excited fluorescent light along an image- acquiring axis that is substantially normal to the substrate, followed by the step 604 of recording an image of the array of bio-material spots on the solid array of a CCD sensor, followed by the step 606 of normalizing the intensity level of pixels in the recorded image using intensity calibration markers.
  • this calibration occurs as an integrated action in the imaging of each array. It is to be distinguished from pre-reading calibration of the overall instrument, a normal but not totally effective procedure.
  • a method for normalizing the intensity level of pixels in the recorded image includes the step 1004 of determining pixels that detect fluorescence from position calibration spots located at corners of an array 1002. The resulting position information is then used to locate pixels that correspond to multiple "data sets" across the two-dimensional image. Each data set contains pixels corresponding to biology spots, and pixels corresponding to an intensity calibration spot. For each data set, including a "data set n,” the method includes the step 1006 of detecting intensity recorded by pixels representing the intensity calibration spot n, the step 1008 of detecting intensity recorded by pixels representing each biology spot in data set n, and the step 1010 of normalizing the intensity data for each biology spot using the intensity of the intensity calibration spot. After intensity data is normalized for each data set, in a final step 1012, the entire image is represented according to the normalized data for all of the data sets.
  • a fluorescence reader-based diagnostic method for a disease for which there is a set of known protein biomarkers in blood or other body constituent, includes the step 1102 of providing a two-dimensional array of different reagents on a substrate.
  • the reagents are respectively specific to bind members of a set of the biomarkers capable of diagnosing the disease.
  • the method then includes the second step 1104 of exposing the array to fluorophore-labeled blood or body- constituent extract of an individual containing the biomarkers if present in the individual's blood or body constituent.
  • the reader While the array is stationary, in a third step 1106, the reader excites the array by simultaneously illuminating the entire two- dimensional array by light at a fluorophore excitation wavelength, employing dark field illumination. In a fourth step 1108, the reader then captures a fluorescence image of the entire two-dimensional excited array on a single frame of an imager comprising a solid state array. The method then includes the step 1110 of analyzing the fluorescence image for the presence of the disease.
  • the assay is a diagnostic immunoassay based on protein derived from blood, and can detect or monitor for malignant cancer, such as ovarian cancer, for initial diagnosis or to monitor patients at risk for relapse. In the last decade, the search for biomarkers that alone, or in combinations with Cal25, could improve prognostic testing for ovarian cancer yielded a number of candidates.
  • Candidate biomarker proteins which have been studied include: HE4 (6), osteopontin (7), prostasin (4, 5) and mesothelm/megakaryocyte potentiating factor (8). Recent reports also suggest that members of the kallikrein serine protease family, particularly kallikrein 10, may also serve as ovarian cancer biomarkers in blood (9, 10, 11). Results from exploratory studies are encouraging and suggest that these proteins either alone, or in combinations with other markers such as CA125, may be useful as prognostic indicators for ovarian cancer.
  • proteomic spectra generated by mass spectroscopy (SELDI-TOF) from sera of ovarian cancer patients and normal individuals and analyzed by an iterative searching algorithm, identified a proteomic profile of five, of as yet unidentified proteins, that completely discriminated the sera of the ovarian cancer patients (12).
  • the discriminatory pattern correctly identified 100% of the ovarian cancer samples including the 36% from early stage patients and showed a specificity (false positive rate) of 95% (12). If the positive predictive value of proteomic pattern technology is supported by population-based trials, these discriminating proteins provide excellent opportunities for developing highly sensitive diagnostic probes (13) which can, given the appropriate technology platforms, be ultimately exploited in routine tests for detecting early stage ovarian cancer.
  • the HE4 (WFDC2) protein is a biomarker for ovarian carcinoma. Cancer Research 63; 3695- 3700.

Abstract

An array reader suitable for clinical purposes for reading a two-dimensional array of photo-responsive markers on a planar substrate that are capable of emitting light upon excitation. The reader is constructed to employ dark field illumination as well as high intensity illumination. High intensity light emitting diodes are preferrably employed for the excitation of the array via a solid internally reflecting homogenizer. Intermediate depth of field collection and imaging optics enable substantial collection of light, with NA in the range of 0.30 to 0.60.

Description

READING OF FLUORESCENT ARRAYS
TECHNICAL FIELD
The field to which this disclosure relates is clinical micro-array technology, for instance clinical research and clinical diagnosis.
BACKGROUND
Micro-array technology has developed over the past decade and more. It is employed in the investigation of biological molecules, in particular, nucleic acid and amino acid materials. Effective use has been made of the technology in understanding the genome and in drug discovery. It has been predicted that the technology would ultimately develop to enable practical use in the clinic, e.g. for clinical investigations and clinical diagnosis, but that prospect has seemed far off. Among reasons for this being only a long-term hope has been the very high cost of the required equipment, the time involved in carrying out assays, and the high level of experience and skill required. As is well known, micro-arrays are used by creating a field of features or spots of different analytes that are tagged or marked if certain components are present. While marking has often been by radioisotope tags, fluorescent tags have come into wide usage for a number of reasons including the ease by which the materials can be handled and out of safety considerations. Typically it is desired to represent an assay by a complete image of an array, or small set of related arrays.
The reader of fluorescent micro-arrays is key to the use of the arrays. The reader records presence and degree of fluorescence at each of the precisely located features in the array in response to exposure to photoexcitation. After consideration of numerous arrangements for reader design, a few successful technologies have found acceptance. These universally have required precise and costly mechanical movements, as well as extensive optics or software. In one case, a rapidly oscillating scanner arm moves a tiny lens for reading one pixel at a time in one coordinate, in a confocal configuration, while the image of the array in the other coordinate is developed by precise, gradual advance using a microscope stage. (The stage is a device that creates precise movements of micron or sub micron accuracy and is costly to manufacture and along with the other components.) With this approach, software is used to assemble the image from the vast array of gathered pixels. Another technique has been to image highly magnified views of portions of the overall array, by use of precision stage movement between the taking of each of the series of magnified images of the small portions of the array, and then electronically merging or "stitching" the small field image frames together to electronically produce an image of the complete array. Prior proposals or speculation for employing a solid state array of sensors to image an entire array at one taking have not resulted in practical solution of the entire set of problems, i.e., simultaneously achieving high accuracy and high speed of operation at reasonable cost. As time has passed, and volume of production of readers has increased, the cost of those imaging systems that are successful, by elegant design, has been reduced from hundreds of thousands of today's U.S. dollars, in some instances to cost somewhat under one hundred thousand dollars. However, the prospect has seemed far off when volume production would enable the price for the readers to approach the cost that might make clinical usage attractive, e.g. a price of the order of twenty five thousand U.S. dollars or less.
SUMMARY
In general, a reader capable of practical clinical use, i.e. in clinical research, clinical diagnosis and monitoring, is found to be possible with a certain combination while observing certain constraints, and it can be implemented with generally available components found in other fields. Embodiments can satisfy the crucial low cost need for a clinical reader, along with need for reasonably high speed and ease of operation, and while achieving the high level of accuracy required for medical use.
It is realized that the basic reader geometry should be based on dark field illumination, e.g. light reaching the two-dimensional array at an acute angle of 20 to 50 degrees, which should be mated with two-dimensional imaging on a solid-state detector array, such as that of a CCD sensor or CMOS array, with mapping on that array being of a scale of the same order of magnitude as the array of biological features. Imaging is performed at normal angle to the plane of the biological array, and is achieved with an optical collection and imaging system having an intermediate range numerical aperture (NA), preferably between NA=0.3 to 0.6, and presently, preferably within the range of
NA=0.4 to 0.5.5. Embodiments within these constraints are capable of imaging an entire array in a single frame, without movement or stitching of components of the array. It is realized that cooperation of the features in the instrument, preferably with further novel enhancements to be described, can make up for the inherent limitations of such an arrangement, i.e. its relatively large depth of field, and, when using preferred relatively inexpensive lighting, such as by high intensity diodes, its non-uniform illumination. The resulting apparatus, because of its simplicity and lack of precise moving parts or expensive optics, can be made available to clinics at a cost that makes the system and technique practical. In such manner, practical, high-speed clinical imaging is made possible even now, and from this, great benefits to medicine and patient care can be obtained.
According to one aspect of the invention, an array reader is provided that is suitable for clinical purposes for reading a two-dimensional array of features on a planar substrate, in which the features carry photo-responsive markers, the markers capable of emitting light upon excitation, the array reader comprising an illumination system for simultaneously exciting multiple photo-responsive markers distributed in a two-dimensional array over the substrate, and an image collection and recording system having a field of view for emissions from the markers on the substrate, wherein the illumination system comprises a light source arranged to flood the two-dimensional array with light at an excitation wavelength, along an illumination path disposed at an angle θ between about 20 and 50° to the plane of the substrate, the image collection and recording system having an image-acquiring axis substantially normal to the plane of the substrate carrying the array, employing a two-dimensional sensor comprising a solid-state array of photosensitive elements, e.g. a charge-coupled device (CCD) or a CMOS array, and the image collection and recording system constructed and arranged to apply an image of the array of markers upon the solid-state array of size of the same order of magnitude as the size of the array, e.g. within a range of magnification of up to about 25% or reduction down to about 75%, the image collection, and recording system having an intermediate numerical aperture NA, to enable recording the image of fluorescence from the excited two-dimensional array with clinical accuracy and without translation of the array.
Preferred embodiments of this aspect of the invention have one or more of the following technical features. The array reader image collection and recording system has its nearest component spaced at least 5 mm, preferably at least 10 millimeter, from the substrate or its support, the component constructed and arranged to provide space below the component for the illumination path to the two-dimensional array on the substrate.
The image collection and recording system has an effective aperture between NA=0.3 and NA=0.60 , preferably the value of NA being between about 4.0 and 5.5.
The image collection and recording system has a field of view on the substrate of areas between about 50 mm2 and 300 mm2.
The illumination system comprises one or more light-emitting diodes.
The illumination system, and especially the diode-based system, is constructed and arranged to provide excitation illumination over the two-dimensional array on the substrate of a power density greater than 30 mW/cm2 and preferably the image collection and recording system includes a timer cooperatively related to the illumination system to provide exposure sufficient to produce a fluence of excitation radiation at the substrate greater than about 15 mJ/cm2 across the two-dimensional array.
The array reader has a field of view of diameter of the order of 10 mm or more.
Each feature of the array of interest is imaged onto a minimum of 50 pixel elements of the solid state array, for example upon CCD or CMOS elements. (In the preferred case shown here the pixels (i.e. sensor elements) of the solid state array are selected to be of 9 micron dimension, albeit, if larger field were to be imaged, using the same arrangement, pixels down to about 4.5 micron may be selected, and more reduction of image may be employed). The array reader is constructed and arranged to deliver to the solid state sensor an image of the field of view that is not magnified, preferably the reader being constructed and arranged to deliver to the solid state sensor array an image of the field of view reduced between about 30% and 50%.
The array reader is constructed to image spots each of diameter at least about 80 micron, preferably at least 100 micron diameter.
The array reader is constructed and arranged to produce, during a single imaging interval, an image of an array of at least 100 spots each of 300 micron diameter, or of at least 400 spots each of 150 micron diameter.
The array reader is combined with a carrier for the array comprising a substrate layer carried by a support body, the image collection and recording system residing on the same side of the substrate as does the array of features such that the path of illumination reaches the array before reaching the support body, the carrier constructed to absorb excitation radiation penetrating beyond the layer, preferably the support body being transparent, e.g. glass, and between the substrate layer and the transparent body resides a substantially opaque adherent layer capable of substantially blocking excitation radiation tending to enter the transparent body, preferably the substantially opaque layer comprising a layer of metal oxide.
The array reader is combined with a carrier for the array in the form of a transparent layer carried by a transparent body, the image collection and recording system lying beyond the transparent body on the same side of the array as the transparent body.
The array reader is combined with a carrier for the array that comprises an ultra- thin substrate layer on a support body, i.e. the substrate having a thickness less than 5 micron, preferably less than about 3 micron. The array reader is combined with a carrier in which the array is disposed on a substrate comprising a clear layer of nitrocellulose or polystyrene.
The array reader is combined with a carrier in which the substrate is a nitrocellulose membrane that is porous at least in its outer region.
The array reader is combined with a substrate carrying excitation energy reference features distributed across the two-dimensional array of features, the image collection and recording system including a normalizing arrangement for normalizing data detected in the vicinity of respective reference features based on the quantity of detected emission from the respective reference features.
The array reader has an illumination system which comprises at least two different light source sub-systems respectively of substantially different wavelengths, each associated with a respective optical system delivering light along a path, the paths of the sub-systems to the substrate lying along respectively different axes, the axes being spaced apart about the substrate, in certain preferred embodiments there being two different light source subsystems the paths of which are disposed on diametrically opposite positions about the substrate.
The array reader has an illuminating system which includes light sources selected respectively to excite Cy3 and Cy5, and the image collection and recording system includes changeable band-pass filters suitable to permit passage of emissions respectively from Cy3 and Cy5 or a single band-pass filter is provided suitable to permit passage of multiple band-pass emissions such as both the band-pass emission of Cy3 and of Cy5.
The image collection and recording system of the array reader is adjustable between at least two settings, the first and second settings constructed and arranged respectively to form a single image of an array format of dimensions 6.5 mm x 9.0 mm and of an array format comprising two separated sub-windows, each of dimensions 4.5 mm x 4.5 mm disposed within a 4.5x 13.5 mm rectangle. The array reader illumination system includes a diode light source and a homogenizer effective to reduce variation in flux density across the field of illumination, in certain preferred embodiments the homogenizer comprising an elongated transparent, internally reflective rod, which may be straight or curved and may have round, square or rectangular cross section, and be twisted or untwisted.
The array reader has an image collection and recording system constructed and arranged to resolve the image on the solid state sensor array at resolution no finer than about 10 micron, in certain preferred embodiments the resolution being between about 12 and 15 micron.
The array reader has an image collection and recording system which includes an interference filter, collection optics of the system preceding the filter constructed to direct collected rays in parallel to the filter, and imaging optics constructed to image parallel rays leaving the filter upon the solid state sensor.
The array reader is constructed to be used with an array support that holds more than one array, and wherem the reader is constructed and arranged to read and process each array as an independent array.
The invention also includes a method of conducting an assay comprising preparing a two-dimensional spotted array of amino or nucleic acid features on a substrate, preferably by spotting liquid samples thereon, in which features in the array carry fluorescent markers and employing the reader of any of the foregoing descriptions to read the array.
Preferred embodiments of this aspect of the invention have one or more of the following technical features.
The assay is a diagnostic immuno assay based on protein derived from blood, in certain embodiments preferably the immunoassay is of an antibody capture configuration, for instance adapted, by immobilized antibodies to detect or monitor for malignant cancer, e.g. to detect ovarian cancer for initial diagnosis or to monitor patients at risk for relapse.
The substrate is disposed within a sealed disposable bio-cassette and imaging is performed through a transparent window visually accessing the substrate, or a transparent body forming a side of the bio-cassette carries the substrate, the substrate being transparent and the array being accessed visually by the array reader through the transparent body and through the substrate.
For any of the array reader embodiments described or for any of the foregoing methods, for reading an array on a substrate, in certain preferred embodiments the array includes intensity calibration markers of fluorescing character generally proportional in emission intensity to excitation level over the range of operable illumination intensities, and the system or method includes forming an image of the array employing the array reader, and normalizing recorded array data based on quantitative data acquired from nearby intensity calibration markers.
Another aspect of the invention is a fluorescence reader-based diagnostic method for a disease for which there is a set of known protein biomarkers in blood or other body constituent, comprising the steps of (1) providing a two-dimensional array of different reagents on a substrate, the reagents respectively specific to bind members of a set of the biomarkers capable of diagnosing the disease, (2) exposing the array to fluorophore-labeled blood or body-constituent extract of an individual containing the biomarkers if present in the individual's blood or body constituent, (3) while the array is stationary, exciting the array by simultaneously illuminating the entire two- dimensional array by light at fluorophore-excitation wavelength, by employing dark field illumination, (4) capturing a fluorescence image of the entire two-dimensional excited array on a single frame of an imager comprising a solid state array, and (5) analyzing (e.g. by computer) the fluorescence image for the presence of the disease. Preferred embodiments of this aspect of the invention have one or more of the following features.
The method is performed in which the step of simultaneously illuminating the entire two-dimensional array is carried out by directing excitation radiation from a diode or set of diodes to produce illumination at a wavelength selected to excite the fluorophore, at a power density of at least 30m /cm2.
The method is carried out in a way in which fluorescence intensity reference features are distributed through the array and the detected radiation from the biomarkers is normalized by the reader based on the response of the references to the illumination.
The method is carried out in a way in which at least 50 pixels of the solid-state sensor represent the image of a feature of the array.
The method is performed in which the biomarkers attach to antibodies.
The method is performed in a way in which the array is formed to immobilize protein biomarkers selected to diagnose presence of ovarian cancer.
Another aspect of the invention is a method of reading an array on a substrate having features that include fluorophores, in which the array includes intensity calibration features of fluorescing character generally proportional in emission intensity to their illumination over the range of operable illumination intensities, including, forming an image of the array employing an array reader, and normalizing recoded array data based on quantitative data acquired during the reading of the array from nearby intensity calibration features within the array.
Preferred embodiments of this aspect of the invention have one or more of the following features. The method is adapted to perform diagnosis for a disease for which there is a set of known protein biomarkers in blood or other body constituent, comprising the steps of (1) providing a two-dimensional array of different reagents on a substrate, the reagents respectively specific to bind members of a set of the biomarkers capable of diagnosing the disease, and including with the array the intensity calibration features (2) exposing the array to fluorophore-labeled blood or body-constituent extract of an individual containing the biomarkers if present in the individual's blood or body constituent, (3) while the array is stationary, exciting the array by simultaneously illuminating the entire two-dimensional array by light at fluorophore-excitation wavelength employing dark field illumination, (4) capturing a fluorescence image of the entire two-dimensional excited array on a single frame of an imager comprising a solid state array, (5) normalizing the recorded array data based on the calibration features in the array and (6) analyzing the fluorescence image for the presence of the disease.
The method is performed by illuminating the entire two-dimensional array for forming the image by directing excitation radiation from a diode or set of diodes to produce illumination at a wavelength selected to excite the fluorophore, at a power density of at least 30mW/cm2.
The method is performed under conditions in which at least 50 pixels of a solid- state sensor represent the image of a feature of the array.
The method is employed to perform a diagnosis in which features of the array include antibodies, in one important case the features of the array are selected to diagnose the presence of ovarian cancer.
DESCRIPTION OF DRAWINGS
FIG. 1 is a diagrammatic view of an array reading system. FIGs. 2 A and 2B are diagrammatic views of illuminating devices for the reader.
FIG. 3 is a plot of relative intensity of illumination versus angle relative to a central axis for a high intensity LED. FIG. 4 A depicts a spotting pin and reservoir suitable to form spots of biological material or intensity calibration spots, while FIG. 4B depicts an array in which the calibration spots are strategically distributed through the array of spots of biological material, FIG. 4C being a magnified view, and FIG. 4D a plan view.
FIG. 5 depicts the mapping of a spot upon the array of solid state detection elements of the sensor.
FIG. 6 is a diagrammatic representation, on highly magnified scale, of a carrier comprising a transparent rigid support body, bearing an opaque layer, ultra-thin substrate and spots of the array on the substrate. Illumination from the same side as the array is shown.
FIG. 7 A is a diagrammatic representation of a preferred clinical array reader, while FIG. 7B shows another clinical array reader.
FIG. 8 illustrates two array formats imageable by the array reader of FIG. 7 A.
FIG. 9 is a diagram representing the steps of an array-reading method. FIG. 10 is a diagram representing the steps of a method for normalizing the intensity level of pixels in the recorded image.
FIG. 11 is a diagram representing the steps of a fluorescence reader-based diagnostic method.
Like reference symbols in the various drawings indicate like elements.
DETAILED DESCRIPTION
Referring to FIG. 1, an array reading system 100 includes an array reader 110, a substrate 102 bearing a two-dimensional array of features 103 (e.g. spots of bio- material such as amino or nucleic acid) some of which, depending on the assay, carry fluorescent material, and a computer 104 for processing images recorded with the array reader 110. The array reader 110 includes an illumination system 120 and an image collection and recording system 140.
During operation, the substrate 102 is positioned, with a positioner 105, below the image collection and recording system 140, with a distance between them h that is large enough for light from the illumination system 120 to flood the two dimensions of the array 103, preferably h having the value of at least 5 mm and generally preferably at least 10 mm. A preferred source of the illuminating light has an output between about
30 mW/cm2 or more, and is preferably a light emitting diode (LED) or array of such diodes. The features on the substrate contain material capable of emitting light within a narrow fluorescence spectrum upon excitation with light of selected wavelength from the illumination system 120. Any available fluorescent dye maybe employed, presently Cy3 and Cy5 being common selections. The image collection and recording system 140 collects the fluorescent light and records a resulting image of the features or spots, the optical system selected to produce a flat field of view. The image-acquiring axis 141 is substantially normal to the plane of the substrate 102. The illumination system 120 uses dark field illumination such that light from the illumination system 120 is directed along a path that has an angle θ between about 20° and 50° to the plane of the substrate 102 to prevent illumination light reflected from the substrate 102 from entering the image collection and recording system 140. Fluorescent light emitted from the spots is collected by imaging optics 142 with an intermediate numerical aperture, e.g. between NA=0.30 to 0.60, and in presently preferred embodiments, in the range between NA=0.40 and 0.55.(all in air) to increase the field-of-view and the amount of light collected. The imaging optics 142 project an image 144 of the array 103 on a two-dimensional array of solid state detecting elements comprising sensor 146. This solid state array is of dimensions of the same order of magnitude as are the dimensions of the array of bio- material spots. The imaging optics system 142 is designed to have such a large field- of-view that the entire array 103 is mapped onto the sensor 146. Generally the two arrays are relatively sized such that a spot of bio-material is resolved on at least 50 pixels, preferably with spot size of the order of 100 micron, of the order of 100 pixels, or with spot size of 300 micron, of the order of 300 pixels.
With such construction, the physical size Dj of the image 144 is approximately the same as the physical size D0 of the array 103, biased toward reduction, i.e. preferably not magnified more than about 25% or reduced more than about 75%. Presently, with reasonably low-cost available components, the array is not magnified, and preferably is reduced in the range between 30% and 50%. This provides the very important feature of there being no requirement to translate the array 103 by a precision stage relative to the reader 110 to acquire the image or stitch together multiple images of small sections to form a single image of the array 103. Referring to FIG.2 A, in a preferred embodiment, the illumination system 120 includes a high intensity LED 122 for emitting light within an excitation band (e.g., green) designed to excite a fluorescence spectrum of a material in a spot (e.g., Cy3). An excitation filter 124 is used to further limit the excitation wavelength band. The spatial distribution of the light is shaped with an optical system such as a pair of lenses 126 and 128 for near uniform illumination of the two-dimensional array 103 on the substrate 102. To provide higher intensity illumination, more than one LED can be distributed about the array 103, also arranged to emit light along a path that has an angle θ between about 20° and 50° to the plane of the substrate 102. ) Referring to FIG. 2B, in another preferred embodiment, the illumination system
120' includes a high intensity LED 132 for emitting light within an excitation band designed to excite a fluorescence spectrum of a material in a spot. An excitation filter 134 is used to further limit the excitation wavelength band. A homogenizer 130 with suitable lenses integral with its ends (not shown) reduces variation in flux density across the field of illumination onto the two-dimensional array 103 situated on the substrate 102. It comprises a solid transparent rod suitably designed or clad to have 100% internal reflection and of length relative to diameter selected to produce the desired homogenization effect, to render the distribution of illumination more uniform function. The homogenizer 130 accepts light up to an acceptance angle of approximately 45°. The end of the homogenizer 130 is arranged to emit light along a path that has an angle θ between about 20° and 50° to the plane of the substrate 102.
There are enhancements that can importantly be combined with the reader to raise performance of the reader to make it practical in various important contexts. 5
Using at least one, and preferably a distribution of energy calibration spots in each array, the detected intensity for spots of an array can be normalized against the detected value of radiation received from near-lying calibration spots during image processing, thus enabling tolerance of non-uniformity in radiation, as may occur in a 0 low cost lighting system. The technique may also be effective to compensate for imprecise location of the array under the reader. FIG. 3 shows a non-uniform illumination pattern generated by a typical high-intensity LED, plotted as relative intensity as a function of angle from the center axis. The intensity of fluorescent light recorded by the solid state sensor array at a location in the image corresponding to a calibration spot is used to infer the local illumination intensity, which is used to normalize the signal level recorded at neighboring spots on the sensor array. Different calibrating spots typically local, respectively, to different sets of spots of unknown intensity are used.
The calibration spots are preferably placed on the substrate along with the array of biological spots for accurate relative placement. FIG. 4A depicts a well of a microwell plate containing a fluorescent calibration composition in which a pin 161 is dipped to receive the composition for spotting a substrate 102 e.g. polyimide polymer (Kapton™) dissolved in a volatile solvent. FIG. 4B shows diagrammatically a spotted array 103 of biological spots 1 6 among which is a pattern of fluorescent calibration spots 164 produced with the composition of FIG. 4A. FIG. 4C is a magnified view of a portion of a substrate 102 containing, in addition to biological spots 166, fluorescent intensity calibration spots 164. FIG. 4D is a diagrammatic plan view, on an enlarged scale, of an array 103 of biological spots 166, showing a relative arrangement of calibration spots 164. This arrangement enables normalization of intensity variations across the entire array 103. The same intensity calibration spots can also be used as spatial fiducials for locating the array or the overall outline of the array may be employed for locating it to the control system.
Taking advantage of the large size of the spots, hence the reasonable size of their image on the solid state array, despite no magnification, another enhancement is the binning of pixels in the solid state array image, which helps to average out random noise. The as-supplied on-board binning capability of a conventional CCD imager may thus be employed to enhance the accuracy of the reading. FIG. 5 shows a section of a CCD near a border of the image of a spot 202 corresponding enabling resolution of a feature in the array by approximately 291 pixels.
Other important enhancements involve provision of special features and characteristics of the substrate and its support which reduce auto-fluorescence capture (i.e., fluorescent light collected from sources other than the fluorescent material in the features of the array). FIG. 6 illustrates important aspects of a preferred substrate 102. An ultra-thin layer 302 of material (e.g., thinner than about 5 microns, preferably less than 3 microns) is comprised e.g. of nitrocellulose or polystyrene. As a film it is transparent, though in other cases an ultra-thin porous nitrocellulose membrane may be employed. The substrate supports the array 103 of features. The being ultra-thin, it limits the amount of fluorescence emitted by the substrate layer 302 itself. An opaque layer 304, such as sputtered metal-oxide helps to prevent illumination light 300 from penetrating into, and exciting fluorescence within, the rigid support 306 below (e.g. the substance of a glass microscope slide). This helps to counter potential auto-fluorescence capture from the support layer 306 caused by the large depth of focus due to not using a high numerical aperture optical system. The array reader 110 enables imaging of an array of fluorescently labeled proteins, as well as other potential widespread uses, such as imaging proteins labeled with luminescent tags, and with other bio-materials labeled with fluorescent or luminescent tags. The array reader 110 may be used to advantage with viruses, peptides, antibodies, receptors, and other proteins; with a wide range of other labeled biological materials including plant, animal, human, fungal and bacteria cells; and with labeled chemicals as well. The array reader 110 is designed for rapid imaging of immunoassay arrays of the size relevant to clinicians, with typically fewer than 1000 spots.
The array reader 110 also enables performing immunoassays of multiple biomarkers (e.g., for ovarian cancer) simultaneously. Diseases with a set of known protein biomarkers in blood or other body constituents, can therefore be diagnosed more easily. After providing a two-dimensional spotted array of reagents on a substrate, the reagent spots are exposed to fluorophore-labeled blood or other body- constituent extracted from an individual suspected of having the disease. The resulting array of spots are then read by the array reader 110.
Referring to FIG. 7A, in a presently preferred embodiment two lighting subsystems are provided at diametrically opposite positions about the array position, employing light sources originally designed for traffic lights. Array reader 400 includes a LumiLed high intensity LED 402 (Luxeon green 535 nm, 5 watt LED, part # LXHL-LM5C available from Lumileds Lighting U.S., LLC, San Jose, CA) with a green peak wavelength for excitation of Cy3, and a second LumiLed high intensity LED 404 (Luxeon red-orange 617 nm, 1 watt LED, part # LXH-MH1B) with a peak wavelength for excitation of Cy5. Both LEDs have a low temperature coefficient, of about 0.04 nm/deg C, and a narrow band peak wavelength tolerance, typically 8nm for Cy5 and 30 nm for Cy3. These LEDs are available with a 10% to 20% conversion efficiency and a typical specification of 110 mW of continuous-wave output power that can be peaked by 50% for a second at low duty cycle to yield about 150 mW, nearly all within the pass bands of a Cy3 excitation filter 406 (Chroma filter part # HQ 535/50, available from Chroma Technologies, Rockingham, NT) and the Cy5 excitation filter 408 (Chroma filter part # HQ 620/60). The f/1 cone (marked by lines 150 at 30° in the illumination pattern shown in FIG. 3) includes 21.5% of the light, or 64.5 mW, (a larger capture is possible with the 45° acceptance angle of the homogenizer of Fig. 2B). However, all the light in the f/1 cone does not transfer through an f/1 lens because of Fresnel reflections at the higher angles. With proper filtering and vignetting it is safe to expect 50 mW (about 33 % transfer efficiency) in a round beam 10 mm in diameter with less than 20% spatial intensity for the red LED 404. Tilting the beam by 45 ° spreads the light over an ellipse enclosing the desired 6.5 x 9.5 mm2 area, so the power density is about 45 mW/cm2. In 1/2 sec, that yields a fluence of 22.5 mJ/cm . For comparison, the excitation energy of a laser-confocal microscope is approximately 5 mWper 10 micron diameter spot for about 7.5 microsecond, yielding a fluence of 48 mJ/cm2. Similar performances are obtained for the green LED 402 with peak absorption for Cy3. In addition to high power and cost efficiency, LEDS have a long life, and allow straightforward implementation of multicolor fluorescence. The green LED 402 uses a pair of Kohler lenses 412, and the red- orange LED 404 uses a pair of Kohler lenses 414, so that both LEDs deliver a nearly uniform beam over the 6.5 x 9.5 mm2 field-of-view of the array 103. The LEDs are mounted on heat sinks available from their supplier.
Positioning of the substrate 102 relative to the viewing axis of the reader is performed by a positioner 105, e.g. a Geneva drive, with spatial resolution e.g. of 0.1 or 0.2 millimeter having a positional accuracy for instance of about 0.1 - 0.2 mm. The positioner 105 can be used to automatically shift from imaging one array to another, either on the same or a different substrate, but of course is not of the precision or cost of a microscope stage and plays no part in generating the components of an image of the array. The same substrate can carry many arrays without the need to precisely position the arrays relative to one another, and the positioner 105 acts to move one after another into position for imaging. Preferably, the substrate has alignment marks, "fiducials", that aid in the positioning, for instance sets of distinctive marks that designate the comers of rectangular arrays. The array 103 is imaged onto the CCD sensor 420 by a pair of commercial CCD lens assemblies 422, 422' (Westech CCD lens assemblies #2105 and #2131, available from Westech Optical Corporation, Penfield, NY), lens 422 being used in an unusual way relative to the purpose of its original design. A band-pass filter 424 (Chroma Technology part # 68030 for Cy5, Chroma part # 57030 for Cy3) located in between the two lenses selectively transmits only light within the excited fluorescence spectra. The image of one 6.5 x 9.5 mm field-of-view (see 502, Fig. 8) is projected onto the CCD sensor 420 reduced by a factor of 0.707, whereas the image of two separated sub- arrays, lying in a rectangle 4.50 x 13.5 mm is reduced by a factor of 0.5.
The lenses are assembled to operate with a 0.42 NA on the object side (facing the array 103). The array 103 can be imaged onto the CCD sensor 420 with the lens assemblies 422 assembled to operate with an NA as large as 0.52.
The CCD sensor 420 is cooled with a Peltier cooler 426 (as in the CCD-based camera from Santa Barbara Instrument Group, Inc., Santa Barbara, CA, Model ST-7x ME) to reduce dark current noise. The cooler 426 has the capability to cool the CCD sensor 420 to 50° C below ambient if necessary. Despite the advantageous cooling, read-out noise, generated upon conversion of the stored charge in a pixel into a voltage, is a dominant source of noise and to the extent its effects are not eliminated, read-out noise determines the minimum light intensity that can be detected. As this noise is random and the fluorescent light from the spots is not, most of its effects can be reduced by the "on board binning," dark field subtraction, time and frame integration, software analysis, and using a large number of pixels imaging each spot.
Referring to FIG. 7B, imaging in a dark field mode may also be accomplished with direct illumination at angle θ as shown and CCD sensor 24 positioned to view the array along axis A normal to the plane of the array via collection optics 27, spaced a distance h from the substrate. In this case the substrate layer may be microporous partially or throughout its depth or may be a solid film or a modified solid film, preferably in any of these cases being an ultra-thin coating or membrane of less than 5 micron thickness. As shown, light for direct illumination enters along an illumination axis A', at an acute angle θ to the plane of the array. Distance h must be selected to enable such direct illumination, with angle θ ranging between about 20° and 50°, here shown at 45°. Light L originates from a source 112a, 112b or 112c of wavelength selected to excite the fluorophore tag of the array, passes via dichroic mirrors 156b, 156c to mirror 116 located to the side that directs the illumination along axis A' at angle θ, onto the fluorophore-tagged array of spots resident on the ultra-thin substrate 20 or 20'. The array of spots may use a carrier that comprises an ultra-thin substrate layer on a support body, or a carrier in the form of a transparent layer carried by a transparent body, the image collection and recording system lying beyond the transparent body on the same side of the array as the transparent body. The fluorescent emissions are collected by lens 27, through a selected filter 28A, B or C, thence through lens 26 to CCD camera 24 under computer control 32. As before, the background subtraction technique is used with this system. The differences between the excitation source and that of FIG. 7 A, come at a significant cost that is counter to the most cost-demanding situations of the clinic, but the geometry and different capabilities of the lighting system of FIG. 7B can have advantages that enjoys the other benefits that have been described.
In an advantageous design, the immunoassay arrays are limited to 400 microassay spots. The array format is then an important design issue. The size and number of pixels of the CCD's chip and the configurations of commercial spotting arrayers are important constraints to be balanced against each other in the design of the reader and array. The size of the array must be matched to the CCD's parameters. On the other hand, spotter pin or tip configurations limit the choice of reservoirs for loading the spotting or printing head with source material, and also limit possible array configurations. Disposable microtiter plates with either 96 or 384 wells are the typical reservoirs used. These constraints are satisfied by the two formats presented schematically in FIG. 8.
Taking into consideration geometric tolerances, a first format 502 field-of-view covers one 6.5 x 9.5 mm2 array, and a second format 504 field-of-view covers two 4.5 x 4.5 mm arrays. Assuming 300-micron diameter spots, 500 microns on center, yielding a spot occupancy of 36%, each spot will be conjugated to about 291 pixels. Assuming 150-micron diameter spots, 333 microns on center, each spot will be conjugated to about 91 pixels. The large number of pixels per spot permits the on board 3x 3 binning option available with the CCD sensor to increase signal-to-noise ratio. The immediate background is subjected to the same averaging to yield a sensitive and reliable fluorescence signal level. Arrays can be formed with each of the formats using either of the two spot sizes. These arrays can be printed with all commercial arrayers/printers, such as the Affymetrix Pin and Ring Arrayer, starting with either 96 or 384 microtiter plates as the source material loading reservoir.
Other methods are useful to raise the signal-to-noise ratio to best define the quality of the image. Longer integration time or the sum of multiple acquisitions of the stationary array are useful to avoid CCD saturation. The signal-to-noise ratio improves as the square root of the ratio of integration time or the number of frames. A 5 second read time versus 0.5 seconds improves the signal-to-noise ratio by approximately 3.16 times. The signal-to-noise ratio can also be increased by increasing the number of
LEDs, e.g. to as many as 4 for each of the 2 wavelengths, to raise the power level to 160mW/cm2. Applied together, these options increase the signal to noise ratio by as much as a factor of 13 by substantially raising the fluence to l,120mJ/cm2. Photo- bleaching, a possible consequence, depending upon the dyes etc., may limit this approach in particular circumstances.
Alternate embodiments can use other types of substrates. For example, the substrate can be a glass slide, or alternatively, a sealed disposable bio-cassette where imaging is performed through a transparent window within the substrate.
Referring to FIG. 9, a method for multi-biomarker assay includes the step 600 of providing a two-dimensional spotted array of amino or nucleic acid features on a substrate, where features throughout the array carry photo-responsive sensitive markers. In the second step, 602, the illumination source of the array reader illuminates the array along an illumination path at an angle θ between about 20 and 50° to the plane of the substrate. In the third step, 603, the image collection and recording system then collects excited fluorescent light along an image- acquiring axis that is substantially normal to the substrate, followed by the step 604 of recording an image of the array of bio-material spots on the solid array of a CCD sensor, followed by the step 606 of normalizing the intensity level of pixels in the recorded image using intensity calibration markers.
It is to be noted that this calibration occurs as an integrated action in the imaging of each array. It is to be distinguished from pre-reading calibration of the overall instrument, a normal but not totally effective procedure.
Referring to FIG. 10, a method for normalizing the intensity level of pixels in the recorded image includes the step 1004 of determining pixels that detect fluorescence from position calibration spots located at corners of an array 1002. The resulting position information is then used to locate pixels that correspond to multiple "data sets" across the two-dimensional image. Each data set contains pixels corresponding to biology spots, and pixels corresponding to an intensity calibration spot. For each data set, including a "data set n," the method includes the step 1006 of detecting intensity recorded by pixels representing the intensity calibration spot n, the step 1008 of detecting intensity recorded by pixels representing each biology spot in data set n, and the step 1010 of normalizing the intensity data for each biology spot using the intensity of the intensity calibration spot. After intensity data is normalized for each data set, in a final step 1012, the entire image is represented according to the normalized data for all of the data sets.
Referring to FIG. 11, a fluorescence reader-based diagnostic method, for a disease for which there is a set of known protein biomarkers in blood or other body constituent, includes the step 1102 of providing a two-dimensional array of different reagents on a substrate. The reagents are respectively specific to bind members of a set of the biomarkers capable of diagnosing the disease. The method then includes the second step 1104 of exposing the array to fluorophore-labeled blood or body- constituent extract of an individual containing the biomarkers if present in the individual's blood or body constituent. While the array is stationary, in a third step 1106, the reader excites the array by simultaneously illuminating the entire two- dimensional array by light at a fluorophore excitation wavelength, employing dark field illumination. In a fourth step 1108, the reader then captures a fluorescence image of the entire two-dimensional excited array on a single frame of an imager comprising a solid state array. The method then includes the step 1110 of analyzing the fluorescence image for the presence of the disease. In a preferred embodiment the assay is a diagnostic immunoassay based on protein derived from blood, and can detect or monitor for malignant cancer, such as ovarian cancer, for initial diagnosis or to monitor patients at risk for relapse. In the last decade, the search for biomarkers that alone, or in combinations with Cal25, could improve prognostic testing for ovarian cancer yielded a number of candidates.
However, in 1995, Berek and Bast reviewed data on 17 different markers (including CA125) and concluded that none was useful in the setting of early stage ovarian cancer (1). However, it has been shown that other tumor markers can complement CA125 and be useful in some circumstances (2). Recently, genomic technologies have dramatically accelerated progress in the search for prognostic ovarian cancer biomarkers. Studies using differential DNA transcriptional profiling of ovarian cancer cell lines and those from ovarian epithelium collectively have identified hundreds of candidate biomarkers (e.g. 3, 4, 5). Some of these new candidate protein biomarkers have been evaluated in exploratory trials. Candidate biomarker proteins which have been studied include: HE4 (6), osteopontin (7), prostasin (4, 5) and mesothelm/megakaryocyte potentiating factor (8). Recent reports also suggest that members of the kallikrein serine protease family, particularly kallikrein 10, may also serve as ovarian cancer biomarkers in blood (9, 10, 11). Results from exploratory studies are encouraging and suggest that these proteins either alone, or in combinations with other markers such as CA125, may be useful as prognostic indicators for ovarian cancer.
There is direct evidence that patterns of multiple biomarkers in blood provide a signal of early stage ovarian cancer. Proteomic spectra generated by mass spectroscopy (SELDI-TOF) from sera of ovarian cancer patients and normal individuals and analyzed by an iterative searching algorithm, identified a proteomic profile of five, of as yet unidentified proteins, that completely discriminated the sera of the ovarian cancer patients (12). In a test of blinded samples, the discriminatory pattern correctly identified 100% of the ovarian cancer samples including the 36% from early stage patients and showed a specificity (false positive rate) of 95% (12). If the positive predictive value of proteomic pattern technology is supported by population-based trials, these discriminating proteins provide excellent opportunities for developing highly sensitive diagnostic probes (13) which can, given the appropriate technology platforms, be ultimately exploited in routine tests for detecting early stage ovarian cancer.
The references referred to are:
1. Berek, JS, RC Bast. 1995 Ovarian cancer screening. The use of serial complementary tumor markers to improve sensitivity and specificity for early detection. Cancer 76 2092-06.
2. Woolas, RP, DH Oran, AR Jeyarajah, RC Bast, JJ Jacobs, 1999. Ovarian cancer identified through screening with serum markers but not by pelvic imaging. 1999. Int. J. Gynecol 9: 497-501. 3. Schummer, M, WV Ng, RE Baumgarner, PS Nelson, B Schummer, DW
Bednarski, L Hassell, BY Baldwin and L. Hood. 1999. Comparative hybridization of an array of 21,500 ovarian cDNAs for the discovery of genes over-expressed in ovarian carcinoma. Gene 238: 375-385.
4. Kwong-Kwok, W, RS Cheng, SC Mok. 2001. Identification of differentially expressed genes from ovarian cancer cells by MICROMAXTM cDNA microarray system. 2001. Biotechniques 30(3): 670-674.
5. Mok, S, J Chao, S Skates, K-K Wong, GK Yu, MG Muto, RS Berkowitz, DW Cramer. 2001. Prostasin, a potential Serum Marker for Ovarian Cancer: Identification Through Microarray Technology. JNCI 93 (19): 1458-1464. 6. Hellstrom, I, J. Raycaft, M Hayden-Ledbetter, J A Ledbetter, M
Schummer, M Mclntosh, C. Drescher, N Urban, KE Hellstrom. 2003. The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma. Cancer Research 63; 3695- 3700.
7. Kim, JH, SJ Skates, T Ude, KK Wong, JO Schorge, CM Feltmate, RS Berkowitz, DW Cramer, SC Mok. 2002. Osteopontin as a potential diagnostic biomarker for ovarian cancer. JAMA 287 (13):1671-9.
8. Scholler N, N Fu, Y Yang, Z Ye, GE Goodman, KE Hellstrom, I Hellstrom. 1999. Soluble member(s) of the mesothelin/megakaryocyte potentiating factor family are detectable in sera from patients with ovarian carcinoma. PNAS USA 96 (20): 11531-6. (found in the L. Hood screening study) 9. Shvartsman, HS, KH Lu, J Lillie, MT Deavers, S Clifford, JI Wolf, GB Mills, RC Bast, DM Gershenson, R Schmandt. 2003. Over expression of kallikrien 10 in epithelial ovarian carcinomas. Gynecol Oncol 90: 44-50.
10. Luo, LY, D Katsaros, A Sorilas, S Fracchiolo, R. Riccinno, IA Rigault de la Longris, DJC Howarth, EP Diamandis 2001. Prognostic value of human kallikrein
10 expression in epithelial ovarian carcinoma. Clin Can Res 7: 2317-2379.
11. Luo, LY, D Katsaros, A Scorialas, S Fracchioli, R Bellino, M van Gramberen, H de Bruijn, A. Henrik, UH Stenman, M Massobrio, AG van der Zee, I Nergote, EP Diamandis. 2003. The serumprognosis. Cancer Res 63: 807-11. 12. Petricoin, EF, AM Ardekani, BA Hitt, PJ Levine, NA Fusaro, MA
Steinberg, GB Mills, C Simone, DA Fishman, EC Kohn, LA Liotta. 2002. Use of proteomic patterns in serum to identify ovarian cancer. Lancet 16: 359 (9306);572-77. 13. Wulfkuhle, JD, LA Liotta, EF Petricoin. 2003. Proteomic applications for the early detection of cancer. Nature Reviews Cancer 3: 267-75. For further disclosure concerning the topics of (1) employing the characteristics of ultra-thin substrate layers in dark field illumination and imaging on a solid state array of sensors of size of order of magnitude of the array of spots, in general and in particular of nitrocellulose and polystyrene, and their methods of manufacture and use, (2) metal oxide and other absorbent layers beneath the substrate that absorb excitation light serving to enhance the operation or make practical a clinical fluorescence reader and (3) formation and utilization of intensity calibration marks in micro-arrays for serving to enhance the operation of a fluorescence reader, in particular one using a high intensity light emitting diode or diode array for excitation illumination, reference is made to a further PCT application being filed simultaneously herewith, which likewise claims priority from U.S. Provisional Serial No. 60/476,512, filed June 6, 2003.
Other features and advantages of the invention will be understood from the foregoing and the claims and are within the spirit and scope of the invention.

Claims

WHAT IS CLAIMED IS:
1. An array reader (110) suitable for clinical purposes for reading a two- dimensional array (103) of features on a planar substrate (302), in which the features carry photo-responsive markers, the markers capable of emitting light upon excitation, the array reader comprising: an illumination system (120) for simultaneously exciting multiple photo- responsive markers distributed in a two-dimensional array over the substrate, and an image collection and recording system (140) having a field of view for emissions from the features on the substrate, wherein the illumination system (120) comprises a light source arranged to flood the two-dimensional array (103) with light at an excitation wavelength, along an illumination path (P) disposed at an angle (θ) between about 20 and 50° to the plane of the substrate, the image collection and recording system (140) having an image-acquiring axis
(141) substantially normal to the plane of the substrate (102) carrying the array, employing a two-dimensional sensor (146) comprising a solid-state array (203, Fig. 4) of photosensitive elements , e.g. a charge-coupled device (CCD) or a CMOS array, and the image collection and recording system constructed and arranged to apply an image of the array of features upon the solid-state array of size (Dc) of the same order of magnitude as the size D0 of the array, e.g. within a range of magnification of up to about 25% or reduction down to 75%, the image collection and recording system (140) having an intermediate numerical aperture NA to enable recording the image of fluorescence from the excited two-dimensional array with clinical accuracy and without translation of the array.
2. The array reader of claim 1 in which the image collection and recording system (140) has its nearest component spaced (dimension h) at least 5 mm, preferably at least 10 mm, from the substrate (102) or its support, the component constructed and arranged to provide space below said component for said illumination path (P) to the two-dimensional array on said substrate.
3. The array reader of claim 1 or 2 in which the image collection and recording system has an effective aperture between NA=0.3 and NA=0.60, preferably the value of NA being between about 4.0 and 5.5.
4. The array reader of claim 1, 2 or 3 in which the image collection and recording system (140) has a field of view (V Fig. 1, Fig. 7B) on the substrate of area between about 50 mm and 300 mm .
5. The array reader of any of the foregoing claims in which said illumination system comprises one or more light-emitting diodes (122).
6. The illumination system of claim 5 constructed and arranged to provide excitation illumination over the two-dimensional array (103) on the substrate (102) of a power density greater than 30 mW/cm .
7. The array reader of claim 6 or 7 in which said image collection and recording system (140) includes a timer that is cooperatively related to the illumination system to provide exposure sufficient to produce a fluence of excitation radiation at said substrate greater than about 15 mJ/cm2 across said two-dimensional array.
8. The array reader of any of the foregoing claims in which the field of view (V) of the array reader has a diameter (D0) of the order of 10 mm or more.
9. The array reader of any of the foregoing claims in which a spot (166, 202) of the array of features is imaged onto at least of 50 pixel elements of the solid state array (203), for example upon CCD or CMOS elements.
10. The array reader of any of the foregoing claims constructed and arranged to deliver to said solid state sensor array (203) an image of the field of view that is not magnified.
11. The array reader of any of the foregoing claims constructed and arranged to deliver to said solid state sensor array an image of the field of view reduced between about 30%) and 50%.
12. The array reader of any of the foregoing claims constructed and arranged to image a two-dimensional array (103) of at least 100 spots (202) each of diameter at least about 80 micron, preferably at least about 100 micron diameter.
13. The array reader of any of the foregoing claims constructed and arranged to produce during a single imaging interval an image of an array of at least 100 spots each of 300 micron diameter or of at least 400 spots each of 150 micron diameter.
14. The array reader of any of the foregoing claims in combination with a carrier (102) for the array comprising a substrate layer (302) carried by a support body
(306), said image collection and recording system (140) residing on the same side of the substrate as does the array of features such that the path (P) of said illumination reaches said array (103) before reaching the support body (306), said carrier constructed to absorb excitation radiation penetrating beyond said layer.
15. The array reader of claim 14 in which said support body (306) is transparent, e.g. glass, and between said substrate layer (302) and said transparent body (306) resides a substantially opaque adherent layer (304) capable of substantially blocking excitation radiation tending to enter the transparent body.
16. The array reader of claim 15 in which said substantially opaque layer (304) comprises a layer of metal oxide.
17. The array reader of claim 1 in which said substrate (302) is in the form of a transparent layer carried by a transparent body (306), the image collection and recording system (140) lying beyond the transparent body on the same side of the array as the transparent body.
18. The array reader of any of the foregoing claims in combination with a carrier (102) for said array (103) that comprises an ultra-thin substrate layer (302) on a support body, i.e. the substrate having a thickness less than about 5 micron, preferably less than about 3 micron.
19. The array reader of any of the foregoing claims in which said array (103) is disposed on a substrate (302) comprising a clear layer of nitrocellulose or polystyrene.
20. The array reader of any of the foregoing claims 1-18 in which said substrate (302) is a nitrocellulose membrane that is porous at least in its outer region.
21. The array reader of any of the foregoing claims in combination with a substrate (302) carrying excitation energy reference features (166) distributed across said two-dimensional array of features, said image collection and recording system (140) including a normalizing arrangement (see Fig. 10) for normalizing data detected in the vicinity of respective reference features based on the quantity of detected emission from the respective reference features.
22. The array reader of any of the foregoing claims in which said illumination system (120) comprises at least two different light source sub-systems (402, 412, 406; 404, 414, 408, see Fig. 7A) respectively of substantially different wavelengths, each associated with a respective optical system delivering light along a path, the paths of said sub-systems to said substrate lying along respectively different axes, the axes being spaced apart about said substrate.
23. The array reader of claim 22 having two said different light source subsystems the paths of which are disposed on diametrically opposite positions about said substrate (Fig. 7A.
24. The areay reader of any of the foregoing claims in which said illuminating system includes light sources (e.g. diodes 402, 404) selected respectively to excite Cy3 and Cy5, and said image collection and recording system (140) includes changeable band-pass filters (424, 424', Fig. 7A) suitable to permit passage of emissions respectively from Cy3 and Cy5 or a single band-pass filter (424) is provided suitable to permit multiple band-pass emission such as both band-pass emissions of Cy3 and Cy5.
25. The array reader of any of the foregoing claims in which the image collection and recording system (140) is adjustable between at least two settings, the first and second settings constructed and arranged respectively to form a single image of an array format of dimensions 6.5 mm x 9.0 mm (504, Fig. 8) and of an array format comprising two separated sub-windows, each of dimensions 4.5 mm x 4.5 mm disposed within a 4.5x 13.5 mm rectangle (502, Fig. 8).
26. The array reader of any of the foregoing claims in which said illumination system includes a diode light source (132) and a homogenizer (130, Fig. 2B) effective to reduce variation in flux density across the field of illumination.
27. The array reader of claim 26 in which said homogenizer (130) comprises an elongated transparent, internally reflective rod, which may be straight or curved and may have round, square or rectangular cross section, and be twisted or untwisted.
28. The array reader of any of the foregoing claims in which said image collection and recording system (140) is constructed and arranged to resolve the image on said solid state array (203, Fig. 4) at resolution no finer than about 10 micron.
29. The array reader of claim 28 in which said resolution is between about 12 and 15 micron.
30. The array reader of any of the foregoing claims in which said image collection and recording system (140) includes an interference filter (424, Fig. 7A), collection optics (422) of said system preceding said filter constructed to direct collected rays in parallel to said filter, and imaging optics (422') constructed to image parallel rays leaving said filter upon said solid state sensor (420).
31. The reader of any of the foregoing claim for use with an array support which holds more than one array, and wherein the reader is constructed and arranged to read and process each array as an independent array.
32. A method of conducting an assay comprising preparing a two- dimensional spotted array of amino or nucleic acid features on a substrate, preferably by spotting liquid samples thereon, in which features throughout the array carry photo- responsive markers and employing the reader of any of the foregoing claims to read the anay.
33. The method of claim 32 in which the assay is a diagnostic im uno assay based on protein derived from blood.
34. The method of claim 32 in which the imrnunoassay is of an antibody capture configuration, employing immobilized antibodies.
35. The method of claim 34 adapted to detect or monitor for malignant cancer.
36. The method of claim 35 adapted to detect ovarian cancer for initial diagnosis or to monitor patients at risk for relapse.
37. The method of any of the claims 32 to 36 in which the substrate is disposed within a sealed disposable bio-cassette (4, Fig. 7B) and imaging is performed through a transparent window visually accessing said substrate, or a transparent body forms a side of said bio-cassette and carries said substrate, said substrate being transparent, such as an ultra-thin nitrocellulose or polystyrene layer, and said array is accessed visually by said array reader through said transparent body and through said substrate.
38. A method employing the array reader of any of the array reader claims, or any of the foregoing method claims, for reading an array on a substrate, in which the array includes intensity calibration features (164) of fluorescing character generally proportional in emission intensity to their illumination over the range of operable illumination intensities, including, forming an image of the array employing said array reader, and normalizing recoded anay data (e.g. for spots 166, Fig. 4C) based on quantitative data acquired from nearby intensity calibration features.
39. A fluorescence reader-based diagnostic method for a disease for which there is a set of known protein biomarkers in blood or other body constituent, comprising the steps of (1) providing a two-dimensional array (103) of different reagents on a substrate, the reagents respectively specific to bind members of a set of said biomarkers capable of diagnosing the disease, (2) exposing the anay to fluorophore-labeled blood or body-constituent extract of an individual containing the biomarkers if present in the individual's blood or body constituent, (3) while the anay is stationary, exciting the anay by simultaneously illuminating the entire two- dimensional anay by light (e.g. by 120, Fig. 1) at fluorophore-excitation wavelength employing dark field illumination, (4) capturing a fluorescence image of the entire two-dimensional excited anay on a single frame of an imager comprising a solid state anay, e.g. by 140, Fig. 1) and (5) analyzing the fluorescence image for the presence of the disease (e.g. by computer 104, Fig. 1).
40. The method of claim 39 in which the step of simultaneously illuminating the entire two-dimensional anay is carried out by directing excitation radiation from a diode (122, 132, 402, 404) or set of diodes to produce illumination at a wavelength selected to excite said fluorophore, at a power density of at least 30mW/cm2.
41. The method of claim 39 or 40 in which fluorescence intensity reference features (164) are distributed through the anay and the detected radiation from said biomarkers is normalized by the reader based on the response of said references to said illumination.
42. The method of any of the foregoing method claims 32-41 in which at least 50 pixels of a solid-state sensor represent the image of a feature of the anay.
43. The method of any of the preceding diagnostic method claims 39-42 in which the biomarkers attach to antibodies.
44. The method of any of the preceding diagnostic method claims 39-43 in which the anay is formed to immobilize protein biomarkers selected to diagnose presence of ovarian cancer.
45. A method of reading an anay on a substrate having features that include fluorophores, in which the anay includes intensity calibration features of fluorescing character generally proportional in emission intensity to their illumination over the range of operable illumination intensities, including, forming an image of the anay employing an anay reader, and normalizing recoded anay data during the reading of the anay from nearby intensity calibration features within the anay.
46. The method of claim 45 adapted to perform diagnosis for a disease for which there is a set of known protein biomarkers in blood or other body constituent, comprising the steps of (1) providing a two-dimensional anay of different reagents on a substrate, the reagents respectively specific to bind members of a set of said biomarkers capable of diagnosing the disease, and including with the array said intensity calibration features, (2) exposing the array to fluorophore-labeled blood or body-constituent extract of an individual containing the biomarkers if present in the individual's blood or body constituent, (3) while the anay is stationary, exciting the anay by simultaneously illuminating the entire two-dimensional anay by light at fluorophore-excitation wavelength employing dark field illumination, (4) capturing a fluorescence image of the entire two-dimensional excited array on a single frame of an imager comprising a solid state anay, (5) normalizing the recorded anay data based on said calibration features in the anay and (6) analyzing the fluorescence image for the presence of the disease.
47. The method of claim 45 or 46 in which the entire two-dimensional anay is illuminated for forming said image by directing excitation radiation from a diode or set of diodes to produce illumination at a wavelength selected to excite said fluorophore, at a power density of at least 30mW/cm .
48. The method of any of the foregoing method claims 45-47 in which at least 50 pixels of a solid-state sensor represent the image of a feature of the anay.
49. The method of any of the preceding employed to perform a diagnosis in which features of the anay include antibodies.
50. The method of claim 49 in which the features of the anay are selected to diagnose presence of ovarian cancer.
EP03788571A 2002-08-16 2003-08-18 Reading of fluorescent arrays Withdrawn EP1546723A4 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US40423702P 2002-08-16 2002-08-16
US404237P 2002-08-16
US43029902P 2002-12-02 2002-12-02
US430299P 2002-12-02
US47651203P 2003-06-06 2003-06-06
US476512P 2003-06-06
PCT/US2003/025702 WO2004017374A2 (en) 2002-08-16 2003-08-18 Reading of fluorescent arrays

Publications (2)

Publication Number Publication Date
EP1546723A2 EP1546723A2 (en) 2005-06-29
EP1546723A4 true EP1546723A4 (en) 2007-03-07

Family

ID=31892097

Family Applications (3)

Application Number Title Priority Date Filing Date
EP03788571A Withdrawn EP1546723A4 (en) 2002-08-16 2003-08-18 Reading of fluorescent arrays
EP03751862.8A Expired - Lifetime EP1546721B2 (en) 2002-08-16 2003-08-18 Substrates for isolating, reacting and microscopically analyzing materials
EP10184800A Withdrawn EP2315027A1 (en) 2002-08-16 2003-08-18 Substrates for isolating, reacting and microscopically analyzing materials

Family Applications After (2)

Application Number Title Priority Date Filing Date
EP03751862.8A Expired - Lifetime EP1546721B2 (en) 2002-08-16 2003-08-18 Substrates for isolating, reacting and microscopically analyzing materials
EP10184800A Withdrawn EP2315027A1 (en) 2002-08-16 2003-08-18 Substrates for isolating, reacting and microscopically analyzing materials

Country Status (4)

Country Link
EP (3) EP1546723A4 (en)
JP (2) JP4678516B2 (en)
AU (2) AU2003269968A1 (en)
WO (2) WO2004018623A2 (en)

Families Citing this family (76)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7270960B2 (en) 2001-08-29 2007-09-18 Pacific Northwest Research Institute Diagnosis of ovarian carcinomas
EP2259050A3 (en) * 2003-08-26 2010-12-22 Blueshift Biotechnologies, Inc. Time dependent fluorescence measurements
BRPI0511003A (en) 2004-05-13 2007-11-20 Applera Corp composite slide structures for microanalytical testing, composite device, and method for fabricating a composite device
JP2008505321A (en) 2004-07-02 2008-02-21 ブルーシフト・バイオテクノロジーズ・インコーポレーテッド Search for phosphor microenvironment
FR2873815B1 (en) * 2004-08-02 2006-11-24 Inodiag Sa READING DEVICE FOR BLADES CARRYING MICRO DEPOSITS BIOLOGICAL REACTION CARRIERS
US7615369B2 (en) * 2004-09-22 2009-11-10 The Regents Of The University Of Michigan Reconfigurable protein patterning using electrowetting microelectrodes
US20060166305A1 (en) * 2005-01-27 2006-07-27 Genetix Limited Animal cell confluence detection method and apparatus
CA2610875A1 (en) 2005-06-06 2006-12-14 Decision Biomarkers, Inc. Assays based on liquid flow over arrays
JP4538746B2 (en) * 2005-09-21 2010-09-08 横河電機株式会社 Biochip and analyzer
EP1801593A1 (en) * 2005-12-22 2007-06-27 Koninklijke Philips Electronics N.V. A method of imaging biological specimens using inorganic nanoparticles as label agents
EP1969136A4 (en) * 2006-01-04 2009-04-15 Fujirebio America Inc Use of he4 and other biochemical markers for assessment of endometrial and uterine cancers
JP2009526993A (en) * 2006-02-15 2009-07-23 リ−コール インコーポレーティッド Fluorescence filtering system and method for molecular imaging
US7923054B2 (en) 2006-04-19 2011-04-12 Gore Enterprise Holdings, Inc. Functional porous substrates for attaching biomolecules
WO2008134811A1 (en) * 2007-05-02 2008-11-13 Fluidyx Pty Ltd A portable device for reading a fluorescent-labelled, membrane based array
WO2009039170A2 (en) * 2007-09-17 2009-03-26 Gentel Biosurfaces, Inc. Integrated protein chip assay
JP5188228B2 (en) * 2008-03-25 2013-04-24 東洋鋼鈑株式会社 Method for detecting fluorescently labeled biologically relevant molecules
US9042967B2 (en) * 2008-05-20 2015-05-26 University Health Network Device and method for wound imaging and monitoring
US20110318822A1 (en) * 2008-08-29 2011-12-29 Chih-Wei Hsieh Analytical strip
WO2010121643A1 (en) * 2009-04-20 2010-10-28 Agilent Technologies, Inc. Identifying calibration markers in multiple detection channels
WO2011034620A2 (en) * 2009-09-21 2011-03-24 Akonni Biosystems Integrated cartridge
US9315857B2 (en) 2009-12-15 2016-04-19 Cellular Research, Inc. Digital counting of individual molecules by stochastic attachment of diverse label-tags
US8835358B2 (en) 2009-12-15 2014-09-16 Cellular Research, Inc. Digital counting of individual molecules by stochastic attachment of diverse labels
WO2011143791A1 (en) * 2010-05-20 2011-11-24 Honeywell International Inc. Microarray reader based on evanescent wave detection
JP2010281842A (en) * 2010-09-24 2010-12-16 Yokogawa Electric Corp Device and method for measuring luminous energy
JP2011017721A (en) * 2010-09-24 2011-01-27 Yokogawa Electric Corp Device and method for measuring luminous energy
CN102121898A (en) * 2011-01-19 2011-07-13 云南烟草科学研究院 Near-infrared sample detection device
ITTO20110567A1 (en) 2011-06-28 2012-12-29 St Microelectronics Srl CARTRIDGE FOR BIOCHEMICAL ANALYSIS, BIOCHEMICAL ANALYSIS SYSTEM AND METHOD TO PERFORM A BIOCHEMICAL PROCESS
EP3441142A1 (en) 2011-11-16 2019-02-13 Becton, Dickinson and Company Methods and systems for detecting an analyte in a sample
EP2820174B1 (en) 2012-02-27 2019-12-25 The University of North Carolina at Chapel Hill Methods and uses for molecular tags
CA2865575C (en) 2012-02-27 2024-01-16 Cellular Research, Inc. Compositions and kits for molecular counting
CN102927953B (en) * 2012-11-08 2015-06-10 西南石油大学 Test method for hydraulics size of shear flow polymer and test device thereof
JP6296457B2 (en) 2013-01-11 2018-03-20 ベクトン・ディキンソン・アンド・カンパニーBecton, Dickinson And Company Low-cost clinical on-site assay device
SG10201806890VA (en) 2013-08-28 2018-09-27 Cellular Res Inc Massively parallel single cell analysis
EP3055676A1 (en) * 2013-10-07 2016-08-17 Cellular Research, Inc. Methods and systems for digitally counting features on arrays
BR112016009958B1 (en) 2013-11-06 2021-08-03 Becton, Dickinson And Company MICROFLUIDIC DEVICE, METHOD, SYSTEM AND KIT
JP6518245B2 (en) 2013-11-13 2019-05-22 ベクトン・ディキンソン・アンド・カンパニーBecton, Dickinson And Company Optical imaging system and method using the same
US9541750B2 (en) 2014-06-23 2017-01-10 Li-Cor, Inc. Telecentric, wide-field fluorescence scanning systems and methods
US11795423B2 (en) 2014-06-26 2023-10-24 The Trustees Of The University Of Pennsylvania Micro-fabricated multi-well chips for long term automated imaging of C. elegans growth and behavior
CN115989999A (en) 2014-07-24 2023-04-21 大学健康网络 Collection and analysis of data for diagnostic purposes
EP3259371B1 (en) 2015-02-19 2020-09-02 Becton, Dickinson and Company High-throughput single-cell analysis combining proteomic and genomic information
EP3262192B1 (en) 2015-02-27 2020-09-16 Becton, Dickinson and Company Spatially addressable molecular barcoding
EP3835431B1 (en) 2015-03-30 2022-11-02 Becton, Dickinson and Company Methods for combinatorial barcoding
WO2016172373A1 (en) 2015-04-23 2016-10-27 Cellular Research, Inc. Methods and compositions for whole transcriptome amplification
WO2016196229A1 (en) 2015-06-01 2016-12-08 Cellular Research, Inc. Methods for rna quantification
KR102395450B1 (en) 2015-09-11 2022-05-09 셀룰러 리서치, 인크. Methods and Compositions for Normalizing Nucleic Acid Libraries
EP3362782B1 (en) * 2015-10-15 2023-07-26 Lumos Diagnostics IP PTY LTD Device for reading an ivd assay
CN109690359B (en) * 2016-04-22 2021-10-15 伊鲁米那股份有限公司 Photonic structure based devices and compositions for use in luminescent imaging of multiple sites within a pixel and methods of using the same
JP6818346B2 (en) * 2016-04-28 2021-01-20 国立大学法人浜松医科大学 Detection kits and methods for direct identification and quantification of nanoparticles by electron microscopy
JP7129343B2 (en) 2016-05-02 2022-09-01 ベクトン・ディキンソン・アンド・カンパニー Accurate molecular barcoding
US10301677B2 (en) 2016-05-25 2019-05-28 Cellular Research, Inc. Normalization of nucleic acid libraries
JP7046007B2 (en) 2016-05-26 2022-04-01 ベクトン・ディキンソン・アンド・カンパニー How to adjust the molecular label count
US10640763B2 (en) 2016-05-31 2020-05-05 Cellular Research, Inc. Molecular indexing of internal sequences
US10202641B2 (en) 2016-05-31 2019-02-12 Cellular Research, Inc. Error correction in amplification of samples
BR112018072475A2 (en) * 2016-07-15 2019-02-19 Panasonic Intellectual Property Management Co., Ltd. method for determining whether or not a test sample has phytopathogenic fungus
WO2018047040A1 (en) 2016-09-08 2018-03-15 Presens Precision Sensing Gmbh Method for calibrated optical measurement and system therefor
AU2017331459B2 (en) 2016-09-26 2023-04-13 Becton, Dickinson And Company Measurement of protein expression using reagents with barcoded oligonucleotide sequences
CN117594126A (en) 2016-11-08 2024-02-23 贝克顿迪金森公司 Method for classifying expression profiles
KR20190077061A (en) 2016-11-08 2019-07-02 셀룰러 리서치, 인크. Cell labeling method
EP3568677A4 (en) * 2017-01-10 2020-10-21 Photoswitch Biosciences, Inc. Systems and methods for detection
EP3568234B1 (en) 2017-01-13 2023-09-06 Cellular Research, Inc. Hydrophilic coating of fluidic channels
US11319583B2 (en) 2017-02-01 2022-05-03 Becton, Dickinson And Company Selective amplification using blocking oligonucleotides
KR20220124280A (en) 2017-06-05 2022-09-13 백톤 디킨슨 앤드 컴퍼니 Sample indexing for single cells
WO2018230575A1 (en) * 2017-06-15 2018-12-20 オリンパス株式会社 Microscope system
JP6994238B2 (en) * 2017-11-07 2022-01-14 村角工業株式会社 Engraving Frost slide glass and engraving method of frost slide glass
GB2571743A (en) * 2018-03-07 2019-09-11 Pop Bio Ltd A method of capturing image data of a luminescent sample and apparatus for the same
ES2945191T3 (en) 2018-05-03 2023-06-29 Becton Dickinson Co High-throughput multi-omics sample analysis
US11365409B2 (en) 2018-05-03 2022-06-21 Becton, Dickinson And Company Molecular barcoding on opposite transcript ends
JP2022511398A (en) 2018-10-01 2022-01-31 ベクトン・ディキンソン・アンド・カンパニー Determining the 5'transcription sequence
EP3894552A1 (en) 2018-12-13 2021-10-20 Becton, Dickinson and Company Selective extension in single cell whole transcriptome analysis
WO2020150356A1 (en) 2019-01-16 2020-07-23 Becton, Dickinson And Company Polymerase chain reaction normalization through primer titration
EP4242322A3 (en) 2019-01-23 2023-09-20 Becton, Dickinson and Company Oligonucleotides associated with antibodies
JP7315356B2 (en) * 2019-03-28 2023-07-26 浜松ホトニクス株式会社 Fluorescence observation device
WO2021092386A1 (en) 2019-11-08 2021-05-14 Becton Dickinson And Company Using random priming to obtain full-length v(d)j information for immune repertoire sequencing
US11649497B2 (en) 2020-01-13 2023-05-16 Becton, Dickinson And Company Methods and compositions for quantitation of proteins and RNA
WO2021231779A1 (en) 2020-05-14 2021-11-18 Becton, Dickinson And Company Primers for immune repertoire profiling
US11739443B2 (en) 2020-11-20 2023-08-29 Becton, Dickinson And Company Profiling of highly expressed and lowly expressed proteins

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH075368A (en) * 1993-06-17 1995-01-10 Fuji Photo Film Co Ltd Fluorescence microscope
DE19630322A1 (en) * 1995-07-28 1997-01-30 Lab Molecular Biophotonics Dark field stimulated fluorescence microscope - has given surface of sample stimulated by zonal light beam with detection of resulting fluorescence via optical objective system
US6040940A (en) * 1998-02-04 2000-03-21 Olympus Optical Co., Ltd. Reflecting fluorescence microscope
WO2001067105A1 (en) * 2000-03-06 2001-09-13 Dade Behring Marburg Gmbh Carriers coated with polysaccharides, their preparation and use

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3013467A (en) 1957-11-07 1961-12-19 Minsky Marvin Microscopy apparatus
JPS61152700A (en) * 1984-12-26 1986-07-11 Susumu Kogyo Kk Membrane supporting immobilized protein
JPH0814582B2 (en) * 1986-02-20 1996-02-14 富士写真フイルム株式会社 Multilayer analytical element for immunoreactant quantification
JPH079087Y2 (en) * 1987-04-13 1995-03-06 大日本印刷株式会社 Inspection sheet
JPS645486A (en) * 1987-06-29 1989-01-10 Hitachi Ltd Cell culture method and apparatus therefor
JPH01240188A (en) * 1988-03-18 1989-09-25 Fuji Photo Film Co Ltd Functional organic thin film
US5720928A (en) * 1988-09-15 1998-02-24 New York University Image processing and analysis of individual nucleic acid molecules
EP0366241A3 (en) * 1988-10-04 1990-05-23 Fisher Scientific Company Device with adsorbent surface and method
US5491097A (en) * 1989-06-15 1996-02-13 Biocircuits Corporation Analyte detection with multilayered bioelectronic conductivity sensors
AU6513790A (en) 1989-09-18 1991-04-18 Biostar Medical Products, Inc. Apparatus for detection of an immobilized analyte
JP2869866B2 (en) * 1989-10-06 1999-03-10 ティーディーケイ株式会社 Container for electrochemiluminescence detection
US5096668A (en) * 1990-04-26 1992-03-17 Difco Laboratories Diagnostic test slide
US5784162A (en) * 1993-08-18 1998-07-21 Applied Spectral Imaging Ltd. Spectral bio-imaging methods for biological research, medical diagnostics and therapy
ATE266195T1 (en) * 1992-09-14 2004-05-15 Stanford Res Inst Int UP-CONVERTING REPORTER MOLECULES FOR BIOLOGICAL AND OTHER TESTING PROCEDURES USING LASER EXCITATION TECHNIQUES
US5552272A (en) * 1993-06-10 1996-09-03 Biostar, Inc. Detection of an analyte by fluorescence using a thin film optical device
BR9607193B1 (en) * 1995-03-10 2009-01-13 multispecific multispecific electrochemical test.
US6207369B1 (en) * 1995-03-10 2001-03-27 Meso Scale Technologies, Llc Multi-array, multi-specific electrochemiluminescence testing
US6017496A (en) * 1995-06-07 2000-01-25 Irori Matrices with memories and uses thereof
US6165798A (en) * 1996-10-10 2000-12-26 University Of British Columbia Optical quantification of analytes in membranes
US6294327B1 (en) * 1997-09-08 2001-09-25 Affymetrix, Inc. Apparatus and method for detecting samples labeled with material having strong light scattering properties, using reflection mode light and diffuse scattering
JP2003521670A (en) * 1997-10-31 2003-07-15 エルジェイエル・バイオシステムズ・インコーポレーテッド Apparatus and method for measuring fluorescence polarization
US6269846B1 (en) 1998-01-13 2001-08-07 Genetic Microsystems, Inc. Depositing fluid specimens on substrates, resulting ordered arrays, techniques for deposition of arrays
US6185030B1 (en) 1998-03-20 2001-02-06 James W. Overbeck Wide field of view and high speed scanning microscopy
US6406921B1 (en) * 1998-07-14 2002-06-18 Zyomyx, Incorporated Protein arrays for high-throughput screening
US6197599B1 (en) * 1998-07-30 2001-03-06 Guorong Chin Method to detect proteins
US6951682B1 (en) * 1998-12-01 2005-10-04 Syntrix Biochip, Inc. Porous coatings bearing ligand arrays and use thereof
EP1163374A2 (en) * 1998-12-01 2001-12-19 Syntrix Biochip, Inc. Arrays of organic compounds attached to surfaces
JP2001215181A (en) * 2000-02-01 2001-08-10 Fuji Photo Film Co Ltd Polymeric support for microscopic observation
EP1255997A2 (en) * 2000-02-18 2002-11-13 Pall Corporation Composite membranes for assaying biomolecules
JP4222756B2 (en) 2000-05-04 2009-02-12 センター フォア ブラッド リサーチ インコーポレイテッド Colloidal composition for solid phase biomolecule analysis preparation identification system
JP2001235473A (en) * 2000-09-21 2001-08-31 Biostar Inc Device for detecting immobilized analyte
CA2427033A1 (en) * 2000-10-26 2002-05-02 Glaucus Proteomics B.V. Products with biofunctional coating
US6905816B2 (en) * 2000-11-27 2005-06-14 Intelligent Medical Devices, Inc. Clinically intelligent diagnostic devices and methods
WO2002057416A2 (en) * 2000-12-12 2002-07-25 Autogenomics, Inc. Improved biochip
US6505921B2 (en) * 2000-12-28 2003-01-14 Eastman Kodak Company Ink jet apparatus having amplified asymmetric heating drop deflection
JP2002214232A (en) * 2001-01-12 2002-07-31 Toray Ind Inc Selectively-bonding-substance-fixed film and method for measuring substance to be tested using the same
US6573051B2 (en) * 2001-03-09 2003-06-03 Molecular Staging, Inc. Open circle probes with intramolecular stem structures
CN101523938B (en) 2006-11-03 2012-02-01 华为技术有限公司 mobile communication method, mobile communication system and access entity

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH075368A (en) * 1993-06-17 1995-01-10 Fuji Photo Film Co Ltd Fluorescence microscope
DE19630322A1 (en) * 1995-07-28 1997-01-30 Lab Molecular Biophotonics Dark field stimulated fluorescence microscope - has given surface of sample stimulated by zonal light beam with detection of resulting fluorescence via optical objective system
US6040940A (en) * 1998-02-04 2000-03-21 Olympus Optical Co., Ltd. Reflecting fluorescence microscope
WO2001067105A1 (en) * 2000-03-06 2001-09-13 Dade Behring Marburg Gmbh Carriers coated with polysaccharides, their preparation and use

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DONAL J. DENVIR, COLIN G. COATES: "Electron multiplying CCD technology: Application to ultrasensitive detection of biomolecules", PROCEEDINGS OF SPIE, BIOMEDICAL NANOTECHNOLOGY ARCHITECTURES AND APPLICATIONS, vol. 4626, 20 January 2002 (2002-01-20), pages 502 - 512, XP002405341 *
HOOPER C. E., ANSORGE R. E.: "Quantitative photon imaging in the life sciences using intensified CCD cameras", BIOLUMINESCENCE AND CHEMILUMINESCENCE, PROCEEDINGS OF THE VITH INTERNATIONAL SYMPOSIUM ON BIOLUMINESCENCE AND CHMILUMINESCENCE, 1 January 1990 (1990-01-01), pages 337 - 344, XP001247827 *

Also Published As

Publication number Publication date
JP2005535909A (en) 2005-11-24
AU2003276852A1 (en) 2004-03-03
AU2003269968A1 (en) 2004-03-11
WO2004018623A3 (en) 2004-04-15
JP2006515065A (en) 2006-05-18
WO2004018623A2 (en) 2004-03-04
EP1546721A4 (en) 2006-10-18
WO2004017374A3 (en) 2004-06-10
EP1546721B1 (en) 2012-08-01
EP1546721A2 (en) 2005-06-29
AU2003276852A8 (en) 2004-03-03
EP1546721B2 (en) 2017-05-17
JP4678516B2 (en) 2011-04-27
EP2315027A1 (en) 2011-04-27
AU2003269968A8 (en) 2004-03-11
EP1546723A2 (en) 2005-06-29
WO2004017374A2 (en) 2004-02-26

Similar Documents

Publication Publication Date Title
EP1546723A2 (en) Reading of fluorescent arrays
US20060127946A1 (en) Reading of fluorescent arrays
US6905885B2 (en) Portable pathogen detection system
US9671345B2 (en) Mapping volumes of interest in selected planes in liquid samples
US20010052976A1 (en) Scanning optical detection system
US20050221279A1 (en) Method for creating chemical sensors using contact-based microdispensing technology
JP2006208294A (en) Device and method for concurrently imaging plasmon resonance and fluorescence
US11300513B2 (en) Device for reading an IVD assay
US9523640B2 (en) Method of fluorescent measurement of samples, and devices therefrom
CN101287980A (en) System for optically analyzing a substance
WO2006038149A1 (en) Method and apparatus for the detection of labeling elements in a sample
Barsky et al. Fluorescence data analysis on gel-based biochips
US20070098596A1 (en) Handheld microarray reader
US8428398B2 (en) Hand-held portable microarray reader for biodetection
US20150102234A1 (en) Systems and method for fluorescence imaging
WO2003085387A1 (en) An apparatus for the detection of laser-induced epifluorescence
US20200011862A1 (en) Apparatus and method for antibody detection
CN217304909U (en) Portable biological detection system
JP2000131237A (en) Microarray chip reading method, and reader therefor
CN113755311B (en) Gene chip reader
RU200805U1 (en) Fluorescent Biochip Analyzer
CN117070336A (en) Fluorescence detection system for digital polymerase chain reaction
KR101188233B1 (en) A diagnosis apparatus for biochip
WO2013156820A1 (en) Simultaneous multiple wavelength fluorescence measurement device, methods therefor and system therefrom

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20050218

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK

RAP3 Party data changed (applicant data changed or rights of an application transferred)

Owner name: DECISION BIOMARKERS INCORPORATED

DAX Request for extension of the european patent (deleted)
RBV Designated contracting states (corrected)

Designated state(s): CH DE FR GB LI

A4 Supplementary search report drawn up and despatched

Effective date: 20070201

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20070301